Pharmaceutical care best practices Implementation and Improvement by Hasan, Tarig
Pharmaceutical care best practices 
Implementation and Improvement 
 
 
A Thesis submitted 
 By 
Tarig Hasan Salim Izzeldin 
 
 In fulfillment of the requirements of the University of Khartoum for the  
Master Degree 
 
 
Under the supervision of  
Dr. Sumia Sir Elkatim Mohamed 
(B. Pharm., M. Pharm, Ph.D.) 
Associate professor of pharmaceutics 
 
 
Department of pharmaceutics  
Faculty of Pharmacy 
University of Khartoum  
 
 
April, 2008 
 
 
 
 
 
 
 
 
 
 
 
Dedication  
 
 
To the memory of my late parents and brother 
 
To my son, daughter and family 
i 
 
ACKNOWLEDGMENTS 
 
Hereby I would like to express my thanks and appreciation to my 
supervisor Dr. Sumia S. Mohamed, B Pharm, M Pharm, PhD, Department of 
Pharmaceutics, Faculty of Pharmacy, University of Khartoum for giving me 
the opportunity to work with this project and for her invaluable advice and 
guidance. 
My special thanks and gratitude to Dr. Hashem Tarifi, MS, PhD, MBA, 
FASHP, Head of pharmacy services-Tawam Hospital for his guidance and 
support. 
Special thanks to colleagues, Dr. Yasir Ibrahim and Dr. Nicole Gebran, 
for their suggestions, ideas and provision of references. 
Special thanks to Dr. Wafa Mohamed Alhasan Ali and my son Hasan 
Tarig (Medical student) for their help in the best practices survey process. 
Special thanks to Mr. Almutaz Mohamed Abdullah for his help in the 
field of statistical data analysis and to Engineer Osama Farid for computer 
designing of Soba Hospital pharmacy layout. 
My thanks also extend to my family and to all who provided any kind 
of assistance to complete this work.   
 
 
 
 
ii 
 
ABSTRACT 
 
The new philosophy of pharmacy practice is the patient-focused 
practice i. e. pharmaceutical care. The purpose of this research is to explore 
the currently provided pharmaceutical care practices in Khartoum state, Sudan 
with an attempt of upgrading and improving hospital pharmacy services to 
reflect the best recommended pharmaceutical care practices. This may help to 
improve medication use process, patient care and safety, treatment outcomes 
and ultimately patients' quality of life. 
The objectives of the study include: situation analysis regarding the 
current pharmaceutical care practice in selected hospitals in Khartoum state, 
set up of a model for the introduction of the new hospital pharmacy services, 
and selection of a hospital pharmacy for the implementation of the model. 
The method of data collection used was a standard survey questionnaire 
regarding best practices assessment based on the minimum standard for 
pharmacies in hospitals.  
Situation analysis regarding the current pharmaceutical care practice in 
selected 18 hospitals in Khartoum state was performed. An interview and site 
visits to the Pharmacy Department at Soba University Hospital were carried 
out for assessment of the current pharmacy services and exploration of the 
possibility for selecting it as a model pharmacy for implementation of the 
suggested new services. 
The findings indicated that all surveyed hospitals do not comply with 
the global minimum standard for hospital pharmacies with varying degrees. 
The overall compliance with best practices was 36.2% ± 11 while the non-
compliance was 63.8% ± 11. Essential and core practices do not exist; 
example, unit dose distribution system and intravenous admixture services.  
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Pharmaceutical care best practices both essential and core at Soba 
University Hospital are severely compromised and below average findings for 
all hospitals surveyed. The overall compliance of the best practices was 
12.9% ± 9.6 while the non-compliance was 87.1% ± 9.6. Two standards 
namely drug information and education and investigational medications do not 
exist. The practices for the rest of the standards are significantly 
underprovided. Therefore, Soba hospital pharmacy was agreed upon by the 
appropriate authorities for the implementation of the model for expansion and 
upgrading. This will allow it to serve as a center of excellence for patient-
focused training and practice.  
As an outcome of this project, the pharmacy was refurbished to include 
the new best practices, namely, proper control of ward medication with unit 
dose dispensing, i.v. admixtures and total parentral nutrition, drug 
information, education and research, quality improvement programs and 
therapeutic drug monitoring (in collaboration with Soba central laboratory).  
This experience will hopefully be expanded to other hospital 
pharmacies in Sudan. 
This study concludes that pharmaceutical care best practices in 
Khartoum state are severely compromised and the minimum standard for 
hospital pharmacies is considerably deficient. 
To bring the pharmacy profession up to the required standard, 
collaboration of concerned authorities and officials at schools of pharmacy, 
hospitals and community pharmacies is required. 
The study recommends that hospital pharmacy services be brought up 
to date, based on the best recommended and evidence based pharmacy 
practices.  
All hospital pharmacies must adhere to the minimum standards for 
hospital practice and avail resources for best practices implementation. 
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	 ا
ﺘﻌﺘﺒﺭ ﺍﻝﻔﻠﺴﻔﺔ ﺍﻝﺠﺩﻴﺩﺓ ﻝﻠﻤﺎﺭﺴﺎﺕ ﺍﻝﺼﻴﺩﻝﻴﺔ ﻫﻲ ﺍﻝﻤﻤﺎﺭﺴﺔ ﺍﻝﺘﻲ ﺘﺭﺘﻜﺯ ﻋﻠﻰ ﺍﻝﻤﺭﻴﺽ 
ﺍﻝﻬﺩﻑ ﻤﻥ ﻫﺫﺍ ﺍﻝﺒﺤﺙ ﻫﻭ ﺍﺴﺘﻜﺸﺎﻑ ﺍﻝﻤﻤﺎﺭﺴﺎﺕ ﺍﻝﺤﺎﻝﻴﺔ ﻝﻠﻌﻨﺎﻴﺔ (. ﺃﻱ ﺍﻝﻌﻨﺎﻴﺔ ﺍﻝﺼﻴﺩﻻﻨﻴﺔ)
 ﺍﻝﺴﻭﺩﺍﻥ ﻤﻊ ﻤﺤﺎﻭﻝﺔ ﺘﺭﻗﻴﺘﻬﺎ ﻭﺘﺤﺴﻴﻥ ﺨﺩﻤﺎﺕ -ﺍﻝﺼﻴﺩﻻﻨﻴﺔ ﺍﻝﻤﻘﺩﻤﺔ ﻓﻰ ﻭﻻﻴﺔ  ﺍﻝﺨﺭﻁﻭﻡ
ﺍﻝﻤﺴﺘﺸﻔﻴﺎﺕ ﻝﺘﻌﻜﺱ ﺃﻓﻀل  ﺍﻝﻤﻤﺎﺭﺴﺎﺕ ﺍﻝﺼﻴﺩﻻﻨﻴﺔ ﺍﻝﻤﻭﺼﻲ ﺒﻬﺎ ﻭﺍﻝﻌﻨﺎﻴﺔ ﺍﻝﺼﻴﺩﻝﺔ ﻓﻰ 
  ﺒﺎﻝﻤﺭﻀﻰ ﻭﻨﺘﺎﺌﺞ ﺍﻝﻌﻼﺝ ﻭﺃﺨﻴﺭﺍﹰ ﺠﻭﺩﺓ ﺍﻝﺤﻴﺎﺓ ﻝﻠﻤﺭﻴﺽ 
ﻴﺸﻤل ﺍﻝﻬﺩﻑ ﻤﻥ ﻫﺫﻩ ﺍﻝﺩﺭﺍﺴﺔ ﺘﺤﻠﻴل ﺍﻝﻤﻭﻗﻑ ﻓﻴﻤﺎ ﻴﺨﺘﺹ ﺒﺎﻝﻤﻤﺎﺭﺴﺎﺕ ﺍﻝﺼﻴﺩﻻﻨﻴﺔ 
ﺩﻴﻡ ﺍﻝﺨﺩﻤﺎﺕ ﺍﻝﺤﺎﻝﻴﺔ ﻭﺍﻝﻌﻨﺎﻴﺔ ﻓﻰ ﺍﻝﻤﺴﺘﺸﻔﻴﺎﺕ ﺍﻝﻤﺨﺘﺎﺭﺓ ﻓﻰ ﻭﻻﻴﺔ ﺍﻝﺨﺭﻁﻭﻡ ﻭﻭﻀﻊ ﻨﻤﻭﺫﺝ ﻝﺘﻘ
  .ﺍﻝﺠﺩﻴﺩﺓ ﻓﻰ ﺼﻴﺩﻝﺔ ﺍﻝﻤﺴﺘﺸﻔﻴﺎﺕ ﻭﺍﺨﺘﻴﺎﺭ ﺼﻴﺩﻝﻴﺔ ﻓﻰ ﻤﺴﺘﺸﻔﻲ ﻝﺘﻨﻔﻴﺫ ﻫﺫﺍ ﺍﻝﻨﻤﻭﺫﺝ
ﻭﻜﺎﻨﺕ ﻁﺭﻴﻘﺔ ﺠﻤﻊ ﺍﻝﺒﻴﺎﻨﺎﺕ ﻫﻲ ﺍﺴﺘﺒﺎﻨﺔ ﺍﻝﻤﺴﺢ ﺍﻝﺒﻴﺎﻨﻴﺔ ﻝﺘﻘﻴﻴﻡ ﺃﻓﻀل ﺍﻝﻤﻤﺎﺭﺴﺎﺕ 
  .ﻭﺘﺭﺘﻜﺯ ﻋﻠﻲ ﺍﺴﺎﺱ  ﺍﻝﺤﺩ ﺍﻷﺩﻨﻲ ﻝﻤﻌﻴﺎﺭ ﺍﻝﺼﻴﺩﻝﻴﺎﺕ ﻓﻰ ﺍﻝﻤﺴﺘﺸﻔﻲ
ﻨﻴﺔ ﺍﻝﺤﺎﻝﻴﺔ ﺒﺎﻝﻤﺴﺘﺸﻔﻴﺎﺕ ﺍﻝﺜﻤﺎﻨﻴﺔ ﻋﺸﺭ  ﺘﺤﻠﻴل ﺍﻝﻤﻭﻗﻑ ﻋﻥ ﻤﻤﺎﺭﺴﺎﺕ ﺍﻝﻌﻨﺎﻴﺔ ﺍﻝﺼﻴﺩﻻ
ﺒﻭﻻﻴﺔ ﺍﻝﺨﺭﻁﻭﻡ،  ﻗﺩ ﺘﻡ ﺍﻝﻘﻴﺎﻡ ﺒﻪ ، ﻭﻗﺩ ﺘﻤﺕ ﺍﻴﻀﺎﹰ ﺯﻴﺎﺭﺓ ﻭﺍﺠﺭﺍﺀ ﻤﻘﺎﺒﻠﺔ ﻓﻰ ﻗﺴﻡ ﺍﻝﺼﻴﺩﻝﺔ 
ﺒﻤﺴﺘﺸﻔﻲ ﺴﻭﺒﺎ ﺍﻝﺠﺎﻤﻌﻲ ﻝﺘﻘﻴﻴﻡ ﺍﻝﺨﺩﻤﺎﺕ ﺍﻝﺼﻴﺩﻝﻴﺔ ﺍﻝﺤﺎﻝﻴﺔ ﻭﺍﺴﺘﻜﺸﺎﻑ ﺍﻤﻜﺎﻨﻴﺔ ﺍﺨﺘﻴﺎﺭﻩ ﻜﻨﻤﻭﺫﺝ 
  .ﻝﺘﻨﻔﻴﺫ ﺍﻝﺨﺩﻤﺎﺕ  ﺍﻝﺠﺩﻴﺩﺓ ﺍﻝﻤﻘﺘﺭﺤﺔ
ﺌﺞ ﺃﻥ ﻜل ﺍﻝﻤﺴﺘﺸﻔﻴﺎﺕ ﺍﻝﺘﻲ ﺘﻡ ﻤﺴﺤﻬﺎ ﻻ ﺘﻠﺘﺯﻡ ﺒﺄﺩﻨﻲ ﺍﻝﻤﺴﺘﻭﻴﺎﺕ ﻭﻗﺩ ﺍﺸﺎﺭﺕ ﺍﻝﻨﺘﺎ
ﻭﻗﺩ ﻜﺎﻨﺕ ﻨﺴﺒﺔ ﺍﻻﻝﺘﺯﺍﻡ ﺒﺄﻓﻀل . ﻭﺍﻝﻤﻌﺎﻴﻴﺭ ﺍﻝﻌﺎﻝﻤﻴﺔ ﺒﺼﻴﺩﻝﻴﺎﺕ ﺍﻝﻤﺴﺘﺸﻔﻴﺎﺕ ﺒﺩﺭﺠﺎﺕ ﻤﺨﺘﻠﻔﺔ 
ﻭﻻ ﻭﺠﻭﺩ .  ١١   ±%٣٦ ،٨ ، ﺒﻴﻨﻤﺎ ﻜﺎﻥ ﻋﺩﻡ ﺍﻹﻝﺘﺯﺍﻡ ﺒﻨﺴﺒﺔ١١ ± %٦٢،٢ ﺍﻝﻤﻤﺎﺭﺴﺎﺕ ﻫﻲ
  .  ﺍﻝﺠﺭﻋﺔ ﺍﻝﻭﺍﺤﺩﺓ ﻭﺨﺩﻤﺎﺕ ﺍﻝﺨﻠﻁ ﺍﻝﻭﺭﻴﺩﻴﺔ  ﺒﻨﻅﺎﻡﻝﻤﻤﺎﺭﺴﺎﺕ ﻀﺭﺭﻴﺔ ﻭﺠﻭﻫﺭﻴﻪ، ﻤﺜل ﺍﻝﺘﻭﺯﻴﻊ
ﻭﺘﻌﺘﺒﺭ ﺃﻓـﻀل ﻤﻤﺎﺭﺴـﺎﺕ ﺍﻝﻌﻨﺎﻴـﺔ ﺍﻝـﺼﻴﺩﻻﻨﻴﺔ ﺍﻝـﻀﺭﻭﺭﻴﺔ ﻭ ﺍﻝﺠﻭﻫﺭﻴـﻪ ﻓـﻰ 
ﻤﺴﺘﺸﻔﻲ ﺴﻭﺒﺎ ﺍﻝﺠﺎﻤﻌﻲ ﻤﺘﺩﻨﻴﺔ ﻭﺘﺤﺕ ﻤﺴﺘﻭﻱ ﻤﺘﻭﺴـﻁ ﺍﻝﻨﺘـﺎﺌﺞ ﻝﻜـل ﺍﻝﻤﺴﺘـﺸﻔﻴﺎﺕ ﺍﻝﺘـﻲ 
، ٩،٦ ± %٢١ ، ٩ ﺃﻤﺎ ﺍﻻﻝﺘـﺯﺍﻡ ﺍﻝـﺸﺎﻤل ﺒﺄﻓـﻀل ﺍﻝﻤﻤﺎﺭﺴـﺎﺕ، ﻓﻘـﺩ ﻜـﺎﻥ . ﺘﻡ ﻤﺴﺤﻬﺎ 
:  ﻭﺒﺎﻝﻤﺜـل، ﻓـﺈﻥ ﺍﺜﻨـﺎﻥ ﻤـﻥ ﺍﻝﻤﻌـﺎﻴﻴﺭ ٩،٦ ± %٧٨ ،١  ﻜﺎﻥ ﻋﺩﻡ ﺍﻻﻝﺘﺯﺍﻡ ﺒﻨـﺴﺒﺔ ﺒﻴﻨﻤﺎ
ﺃﻤـﺎ ﺍﻝﻤﻤﺎﺭﺴـﺎﺕ ﻝﺒﻘﻴـﺔ . ﺍﻷﺒﺤـﺎﺙ ﻻ ﻭﺠـﻭﺩ ﻝﻬـﺎ ﺃﺩﻭﻴـﺔ ﻤﻌﻠﻭﻤﺎﺕ ﺍﻷﺩﻭﻴﺔ ﻭﺍﻝﺘﻌﻠﻴﻡ ، ﻭ 
ﻝﺫﺍ، ﻓـﺈﻥ ﺼـﻴﺩﻝﻴﺔ ﻤﺴﺘـﺸﻔﻲ ﺴـﻭﺒﺎ ﻗـﺩ ﺍﺘﻔـﻕ . ﺍﻝﻤﺴﺘﻭﻴﺎﺕ ﻭﺍﻝﻤﻌﺎﻴﻴﺭ، ﻓﻬﻲ ﻨﺎﻗﺼﺔ ﺘﻤﺎﻤﺎﹰ 
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ﻭﻫـﺫﺍ ﺴﻴـﺴﻤﺢ ﻝﻬـﺎ . ﺍﻝﻨﻤﻭﺫﺝ، ﻝﻠﺘﻭﺴـﻊ ﻭﺍﻝﺘﺭﻗﻴـﺔ ﻋﻠﻴﻬﺎ ﻤﻥ ﻗﺒل ﺍﻝﺴﻠﻁﺎﺕ ﺍﻝﻤﺨﺘﺼﺔ ﻝﺘﻨﻔﻴﺫ 
 .ﺃﻥ ﺘﻘﺩﻡ ﺍﻝﺨﺩﻤﺔ ﻜﻤﺭﻜﺯ ﻝﻼﻤﺘﻴﺎﺯ ﻝﻠﺘﺩﺭﻴﺏ ﻭﺍﻝﻤﻤﺎﺭﺴﺔ ﺍﻝﻤﺭﻜﺯﺓ ﻋﻠﻰ ﺍﻝﻤﺭﻴﺽ
 ﻭﻜﻨﺘﺎﺝ ﻝﻬﺫﺍ ﺍﻝﻤﺸﺭﻭﻉ، ﻓﻘﺩ ﺠﺩﺩﺕ ﻤﺒﺎﻨﻲ ﺍﻝﺼﻴﺩﻝﻴﺔ ﻝﺸﻤل ﺃﻓﻀل ﺍﻝﻤﻤﺎﺭﺴﺎﺕ ﺍﻝﺠﺩﻴﺩﺓ، 
ﺔ ﺍﻝﻭﺍﺤﺩﺓ  ﺍﻝﺠﺭﻋ ﺃﻱ، ﺍﻝﺴﻴﻁﺭﺓ ﺍﻝﺼﺤﻴﺤﺔ ﻋﻠﻰ ﺍﻻﺩﻭﻴﻪ ﻓﻲ ﺍﻝﻌﻨﺒﺭ، ﻤﻊ ﺘﻘﺩﻴﻡ ﺍﻝﺘﻭﺯﻴﻊ ﺒﻨﻅﺎﻡ
ﻭﺨﺩﻤﺎﺕ ﺍﻝﺨﻠﻁ ﺍﻝﻭﺭﻴﺩﻴﺔ ﻭ ﺍﻝﺘﻐﺫﻴﺔ ﺍﻝﻭﺭﻴﺩﻴﻪ ، ﻤﻌﻠﻭﻤﺎﺕ ﺍﻷﺩﻭﻴﺔ ﻭﺍﻝﺘﻌﻠﻴﻡ ﻭﺒﺭﺍﻤﺞ ﺘﺤﺴﻴﻥ 
  (.ﺒﺎﻝﺘﻌﺎﻭﻥ ﻤﻊ ﻤﻌﻤل ﺴﻭﺒﺎ ﺍﻝﻤﺭﻜﺯﻱ)ﺍﻝﻨﻭﻋﻴﺔ ﻭﺭﺼﺩ ﺍﻷﺩﻭﻴﺔ ﺍﻝﻤﻌﺎﻝﺠﺔ 
  .ﻭﻫﺫﻩ ﺍﻝﺘﺠﺭﺒﺔ، ﻨﺘﻤﻨﻲ ﺃﻥ ﺘﺘﻭﺴﻊ ﺇﻝﻰ ﺍﻝﺼﻴﺩﻝﻴﺎﺕ ﺍﻷﺨﺭﻯ ﺒﺎﻝﻤﺴﺘﺸﻔﻴﺎﺕ ﻓﻲ ﺍﻝﺴﻭﺩﺍﻥ
ﺔ ﺍﻝﺼﻴﺩﻻﻨﻴﺔ ﻓﻲ ﺃﻓﻀل ﻤﻤﺎﺭﺴﺎﺘﻬﺎ ﻓﻲ ﻭﻻﻴﺔ ﺍﻝﺨﺭﻁﻭﻡ، ﺘﺨﺘﺘﻡ ﻫﺫﻩ ﺍﻝﺩﺭﺍﺴﺔ ﺒﺄﻥ ﺍﻝﻌﻨﺎﻴ
  .ﻤﺘﺩﻨﻴﺔ ﺒﺸﻜل ﻜﺒﻴﺭ ﻭﺃﻥ ﺃﺩﻨﻲ ﺍﻝﻤﺴﺘﻭﻴﺎﺕ ﻝﺼﻴﺩﻝﻴﺎﺕ ﺍﻝﻤﺴﺘﺸﻔﻲ ﻗﺩ ﻨﻘﺼﺕ ﺒﺸﻜل ﻜﺒﻴﺭ
ﻭﻝﻼﺭﺘﻔﺎﻉ ﺒﻤﻬﻨﺔ ﺍﻝﺼﻴﺩﻝﺔ ﺇﻝﻰ ﺍﻝﻤﺴﺘﻭﻱ ﺍﻝﻤﻁﻠﻭﺏ، ﻴﺠﺏ ﺘﺤﻘﻴﻕ ﺍﻝﺘﻌﺎﻭﻥ ﺒﻴﻥ ﺍﻝﺴﻠﻁﺎﺕ 
  .ﻴﺎﺕ ﺍﻝﻤﺠﺘﻤﻊﻴﻥ ﻓﻲ ﻤﺩﺍﺭﺱ ﻭﻜﻠﻴﺎﺕ ﺍﻝﺼﻴﺩﻝﺔ ﻭﺍﻝﻤﺴﺘﺸﻔﻴﺎﺕ ﻭﺼﻴﺩﻝﻬﺘﻤﺍﻝﻤﺨﺘﺼﺔ ﻭﺍﻝﻤ
ﻭﺘﻭﺼﻲ ﻫﺫﻩ ﺍﻝﺩﺭﺍﺴﺔ ﺃﻥ ﺘﺠﺩﺩ ﻭﻴﺘﻡ ﺘﺤﺩﻴﺙ ﺍﻝﺨﺩﻤﺎﺕ ﺍﻝﺼﻴﺩﻝﻴﺔ ﻓﻲ ﺍﻝﻤﺴﺘﺸﻔﻴﺎﺕ، ﻋﻠﻰ 
  .ﺃﺴﺎﺱ ﺃﻓﻀل ﺍﻝﺘﻭﺼﻴﺎﺕ ﻭﺍﻝﺸﻭﺍﻫﺩ ﺍﻝﻌﻠﻤﻴﻪ  ﻓﻰ ﺍﻝﻤﻤﺎﺭﺴﺎﺕ ﺍﻝﺼﻴﺩﻝﺔ
ﻭﻴﺠﺏ ﻋﻠﻰ ﻜل ﺼﻴﺩﻝﻴﺎﺕ ﺍﻝﻤﺴﺘﺸﻔﻴﺎﺕ ﺃﻥ ﺘﻠﺘﺯﻡ  ﺒﺎﻝﺤﺩ ﺍﻷﺩﻨﻲ ﻝﻤﻌﺎﻴﻴﺭ ﺍﻝﻤﻤﺎﺭﺴﻪ  ﻓﻰ 
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1. INTRODUCTION AND LITERATURE REVIEW 
 
1.1. Introduction 
Pharmaceutical care is the direct, responsible provision of medication 
related care for the purpose of achieving definite outcomes that improve 
patient’s quality of life. Therefore, the mission of the pharmacist is to provide 
pharmaceutical care according to the best internationally recommended 
criteria (Helper and Strand, 1990). 
Patient care consists of integrated domains of care including medical 
care, nursing care and pharmaceutical care. The pharmacist contributes his 
knowledge and skills to ensure optimal outcomes from the use of medications. 
This will be direct patient care or the pharmacist cooperated directly with 
other professionals and the patient in designing, implementing and monitoring 
therapeutic plan intended to produce definite therapeutic outcomes that 
improve the patient’s quality of life. Therefore, the goal of pharmaceutical 
care is to improve the patient quality of life through achievement of definite 
medication related outcomes (Helper and Strand, 1990; Gold and Fedder, 
1992) 
Nowadays, pharmacists have an extremely important role to play in 
drug use control, contributing their specialist knowledge about medications to 
ensure positive patient outcomes and cost-effective use of drugs (LeBlanc and 
Dasta, 2005). Their service is an integrated part of modern medicine. This is 
seen in areas like total parentral nutrition, therapeutic drug monitoring, patient 
counseling and education, drug information, proper control of ward 
medication with unit dose drug distribution system, comprehensive IV 
admixture preparations in an aseptic environment, quality improvement 
program etc.  
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Pharmacists can improve the development of pharmaceutical care best 
practices by ensuring the evidence-based selection of pharmacy practices, 
processes, activities, functions and medication use systems (ASHP, 2004). 
They should take leadership roles in the development, implementation and 
assessment of pharmaceutical care best practices. 
Pharmacists can optimize the medication therapy by using their clinical 
skills and implementation of clinical services within the hospitals. 
In Sudan there are twelve schools of pharmacy and a considerable 
number of pharmacists; 5008 according to the Ministry of Health Annual 
Report (MOH, 2007). The majority of them work at hospitals in public sector 
or at community pharmacies in private sector. The current practice is still 
product-oriented .i.e. dispensing. Therefore it is high time that the profession 
of pharmacy should be advanced to meet the global pharmacy practice levels 
and it is a challenge and good opportunity for pharmacists to use their gained 
knowledge in advancing the profession. 
This study is intended to explore the current hospital pharmacy practice 
in Khartoum state and compare it with the globally recommended minimum 
standards for pharmacies in hospitals, in an attempt to foster improvements in 
hospital pharmacy practice and patient care. It evolved because of the global 
reprofessionalization of the pharmacy profession and development of patient-
centered approaches as the new philosophy of the practice which dictates a lot 
of restructuring of the current pharmacy practice in Sudan.  
The study consists of 4 chapters. Chapter 1 provides an introduction and 
literature review regarding global pharmaceutical care best practices 
standards. This offers the minimum standard for pharmacies in hospitals that 
must be available otherwise the pharmaceutical care will be compromised. 
These can be summarized as leadership and practice management, drug 
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information and education, medication distribution and control, optimizing 
medication therapy, facilities; equipment, information resources, and 
investigational medications.  
Effective pharmacy practice management is recommended for delivery 
of consistent pharmaceutical care in addition to continuous improvement in 
patient care outcomes. It provides guidelines to assist pharmacy managers in 
recruitment and selection of pharmacy staff. It also establish quality 
performance improvement plan for the Pharmacy department, propose 
outcomes, process and clinical quality improvement indicators for pharmacy 
practice and offer operational, clinical and administrative policies and 
guidelines manual to serve as a comprehensive reference for pharmacy staff. 
Drug information and education was explored. In this part, drug 
information activities, handling, requests, resources and reference materials 
were described. The patient education and counseling part present guidelines 
for providing effective education and training, skills required by pharmacist, 
environment for providing patient education and counseling, education 
counseling process, content and documentation of patient education.  
The primary function of the hospital pharmacy is the management of 
medications in the hospital, including their procurement, storage, 
compounding, preparing, dispensing and distribution. This chapter describes 
the methods of different drug distribution systems and their advantages. It 
portrays the unit dose drug distribution practice, unit dose system 
implementation and requirements, advantages, decentralization of pharmacy 
services, flow of medications and medication orders and flow chart of unit 
dose cassette filling. 
A provision of comprehensive Intravenous Admixture program was 
given. This presents clean room requirements, aseptic technique, risk level 
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classifications, personnel education, training and evaluation, expiration dating, 
process validation, and finally infection control quality testing of sterile 
products. 
Medication safety represents the cornerstone on pharmaceutical care 
practice. Here, the standards for high alert medication management, look alike 
sound alike drugs, do not use dangerous abbreviation, and adverse drugs 
reactions reporting were presented. In addition to medication errors reporting 
and implementation procedures. 
Pharmacy informatics were discussed. This comprised pharmacy 
application software, computerized physician order entry, automated 
medication dispensing devices, the pharmacy responsibilities towards quality 
assurance and bar coding. Their advantages and barriers were highlighted. 
The optimizing medication therapy section provides definition, goals 
and planning of pharmaceutical care, direct patient care and the role of 
pharmacist in direct patient care. 
Chapter 2; methodology, consisted of three parts. In part one 
comprehensive critical appraisal of the literature was presented. This is to 
provide information regarding the global best practices of pharmacies in 
hospitals and attempt to select the minimum standards for the practice, without 
which the hospital pharmacy is declared below standard. Part two, studied and 
examined the pharmaceutical care best practices in selected hospitals in 
Khartoum State. Here the current situation of the practice for the different 
recommended standards was investigated using a self-structured best practice 
assessment questionnaire. In the third part a proposal for upgrading and 
expansion of Soba pharmacy services was provided. It emphasized on the 
implementation of modern pharmaceutical care services at Soba university 
hospital pharmacy. 
5 
 
Chapter 3 provides results and discussion of the findings of best 
practices assessment survey and the outcome of the upgrading and expansion 
of Soba Hospital Pharmacy services. Future perspectives regarding 
implementation of best practices at Soba Hospital were also discussed. These 
present some services that can be summarized as follows. 
a) Pharmacist managed clinics e.g. anticoagulant clinic as an example 
of direct patient care. Here the purpose of pharmacist managed anticoagulant 
clinics, objectives, advantages, types of patients, point of care testing devices 
for Prothrombin time – International normalized ratio (PT-INR), therapeutic 
monitoring, staffing, patient education, clinic and reference materials and 
service audit for the clinic were discussed.  
b) Therapeutic drug monitoring at hospital level.  
c) Parentral nutrition: This provides guidelines to establish appropriate 
and safe practices regarding ordering, preparing, administering, storing 
and monitoring of parentral nutrition (PN). 
d) Medication reconciliation as safety standard. 
Chapter 4 concludes the challenges required to actualize the 
pharmaceutical care vision. It recommends consideration for changing the 
pharmacy practice in Sudan toward the pharmaceutical care vision. i.e. 
patient- focused practice.  
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1.2 LITERATURE REVIEW 
1.2.1 MINIMUM GLOBAL STANDARDS FOR PHARMACEUTICAL 
CARE BEST PRACTICES AT PHARMACIES IN HOSPITALS 
 
American society of Health-System Pharmacist (ASHP), Manitoba 
Pharmaceutical Association, Canada and Joint Commission International 
provide hospital standards of practice and guidelines on practice in hospital 
pharmacy. On literature review, these guidelines represent the minimum level 
of practice that all hospitals must have in constant basis. Failure to provide 
any of these services may compromise the overall quality of pharmaceutical 
care. Other standards of excellence and polices for services are not presented. 
These guidelines can serve as a guide for the provision of the 
pharmaceutical services in hospitals and are useful in evaluating and assessing 
the scope and quality of these services (ASHP, 1995; Manitoba, 2004 and 
JCIA, 2007). 
Six minimum standards for pharmacies in hospitals can be identified 
which are: 
 
Standard 1- Leadership and practice management 
Effective leadership and practice management are necessary for the 
delivery of pharmaceutical care services in a manner consistent with hospital’s 
and patient’s needs in addition to continuous improvement of in patient care 
outcomes (Zilz et al., 2004) 
Pharmaceutical service management must focus on the pharmacist’s 
responsibility to provide pharmaceutical care and to develop an organizational 
structure to support that mission. The pharmacy director should be responsible 
for setting the short and long tern goals of the department, developing plan 
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and schedules for achieving these goals, directing and implementing and 
follow-up the plans, determining whether the goals and the schedules are 
being met and instituting corrective actions when necessary. 
The minimum standards for practice management shall observe the 
followings: 
Director’s education and training: The pharmacy director shall be 
professionally competent, qualified pharmacist with knowledge about hospital 
pharmacy practice and management. Advanced pharmacy or management 
degree is desirable. 
Pharmacy mission: The pharmacy shall have a written mission statement 
reflecting both patient care and operational responsibilities. It shall be 
consistent with the hospital mission and understood by all pharmacy staff.  
Support personnel:  Sufficient support personnel (pharmacy technicians, 
clerks and secretaries) shall be employed to facilitate the implementation of 
pharmaceutical care. 
Work schedules and assignments: The director of pharmacy shall ensure that 
work schedules and assignments optimize the use of personnel and resources 
Education and training: All staff must posses the education and training 
needed to fulfill their responsibilities. All pharmacists and pharmacy 
technicians must participate in relevant continuing education activities as 
necessary to maintain and enhance their competence.  
Recruitment and selection of personnel: Shall be on the basis of job-related 
qualifications or job-related prior performance and experience  
Orientation of personnel: Orientation program for the new arrivals to the 
hospital, pharmacy and their respective positions must be an established.  
Performance evaluation: Procedures for the evaluation of the staff 
performance shall exist. 
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Job descriptions: Pharmacy positions shall be clearly defined and written job 
descriptions for all categories of the pharmacy staff must exist and be revised 
as necessary. 
Operational manual: Policies and procedures guidelines for all pharmacy 
functions shall exist. The operation manual shall cover all administrative, 
operational and clinical functions. It must be revised when necessary to reflect 
changes in policies and procedures and reviewed every 2 years. All pharmacy 
staff should be familiar with the content s of the manual. 
Drug expenditures: Policies and procedures for managing drug expenditures 
shall exist.  
Committee involvements: Pharmacists should participate in the committees 
responsible for establishing medication related policies and procedures and in 
the committees responsible for provision of patient care. 
Quality improvement: A program for continuous, systematic quality 
improvement of pharmacy and medication use process shall exist. This 
program should be integrated with the hospital quality improvement activities. 
Activities (indicators) related to the medication use process should be 
routinely performed and outcomes should be shared with the pharmacy staff. 
24-hour pharmaceutical service: 24-Hours coverage should be provided if 
possible. It should exist in all hospitals with clinical programs requiring 
intensive medication therapy. (e.g., transplant, open heart surgery programs, 
and neonatal intensive care units). When the 24-hour coverage is not feasible, 
on call pharmacist must be available. 
Standard 2- Drug information and education 
The pharmacist should provide patient-specific drug information and 
accurate information about drugs to other pharmacists, health care 
professionals and patients as appropriate. Therefore an up-to-date drug 
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information service shall exist. Electronic information is desirable. 
Appropriate drug information resources should be available in the patient care 
areas. 
The following must be considered regarding drug information and 
education:  
Drug information requests: Responses to drug information requests shall be 
provided in accurate and timely manner with a continuous process to access 
the quality of these responses.  
Medication-therapy monographs: Shall be available for the medications 
under consideration for the formulary addition or deletion. The monographs 
should be based on an analytical review of patient literature. Each monograph 
shall include a comparative therapeutic and cost assessment of each 
medication. 
Patient education: Pharmacists should actively participate in patient 
education. These activities shall be coordinated with the other health care 
professionals as needed.  
Dissemination of drug information: Pharmacists should keep the hospital 
staff informed about the use of medication on an ongoing basis. (e.g., 
publications, presentations and programs). They should ensure timely 
dissemination of drug product information (e.g., drug recalls and labeling 
changes).   
 
Standard 3- Optimizing medication therapy 
An important aspect of pharmaceutical care is optimizing the 
medication use. This must include processes designed to ensure safe and 
effective use of medications. Pharmacists in collaboration with other health 
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care professionals must develop policies and procedures for ensuring the 
quality of medication therapy (ASHP, 2004). 
The followings must be considered regarding optimizing medication 
therapy: 
Medical record documentation: Clinical actions and recommendations by 
pharmacist should be documented in patient medical record.  
Medication histories: Pharmacists should have an access to medication 
histories for each patient medical record. A pharmacist-conducted medication 
history for each patient is desirable. 
Medication orders: All medications orders must be verified and reviewed for 
appropriateness by a pharmacist before dispensing. Medication orders 
clarification and intervention should be documented either at the patient 
medical record or the pharmacy copy of the medication order or prescription 
and must be communicated to the appropriate health care professional. 
Medication-therapy monitoring: Shall be conducted for appropriate patients 
and medication use. Carried through assessments of the therapeutic 
appropriateness of the patient’s medication regimen, therapeutic duplication in 
the patient’s medication regimen, appropriateness of the route and method of 
administration of the medication, patient compliance with the prescribed 
medication regimen, drug-drug, drug-food, drug-laboratory test and drug-
disease interactions, clinical and pharmacokinetic laboratory data to evaluate 
the efficacy and to anticipate toxicity and adverse effects and physical signs 
and clinical symptoms relevant to the patient medication therapy (ASHP, 
2004). 
Therapeutic purpose: Prescribers should be encouraged to state the condition 
being treated or the therapeutic purpose of medications at all prescriptions and 
medication orders. 
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Medication-use evaluation (MUE): A medication use program shall exist to 
ensure that medications are used appropriately, safely and effectively. 
Medication-use policy development: The pharmacist shall be a member of all 
committees that make decisions concerning medication use.  
Documentation of pharmaceutical care and outcomes: An ongoing process 
for consistent documentation of pharmaceutical care and patient outcomes 
shall exist. 
Clinical care plans: Pharmacists must be involved in the development of 
clinical care plans involving medication therapy. 
 
Standard 4- Medication distribution and control  
The pharmacy shall be responsible for the procurement, distribution and 
control of all drugs used in the hospital and policies and procedures governing 
these functions shall be developed as follows: 
Medication orders: All medications orders shall be reviewed by a pharmacist 
and assessed against the patient profile before dispensing. 
Formulary: A formulary of approved medications for use at the hospital shall 
be maintained by the pharmacy.  
Prescribing: Medications shall be prescribed by individuals who have 
prescribing privileges only. The pharmacy shall ensure that prescribers 
comply with prescribing standards, like approved terminology and 
abbreviations to be use throughout the hospital. 
Medication administration: Only personnel who are authorized by the 
hospital shall be permitted to administer medications to a patient. 
Extemporaneous compounding: Drug formulations which are not available 
commercially shall be prepared by pharmacy and compounded against 
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evidence based reference. Extemporaneous prepared formulations must be 
logged in an extemporaneous compounding log book.   
Sterile products: All sterile products shall be prepared and labeled in a clean 
room under aseptic technique by appropriately trained personnel. Quality 
assurance procedures for the preparation of sterile products shall exist.  
Unit dose packaging: Whenever possible, medications shall be available in 
single-unit dose-packages and ready-to-administer form. Manipulation of 
medications before administration by final users should be minimized.  
Medication storage: Medications shall be stored under proper conditions of 
sanitation, ventilation, temperatures, light, moisture, segregation and security 
to ensure medication integrity and personnel safety.  
Adverse drug reactions: An on going program for monitoring, reporting and 
preventing adverse drug reactions shall be developed.  
Medication errors: Pharmacists with other health care professionals shall 
establish policies and procedures for medication error reporting, ongoing 
monitoring and review. Medications errors analysis outcomes should be used 
as an educational and quality improvement tool. 
Drug product recalls: A written policy shall exist for drug product recalls. 
There should be an established process for removing from use any drugs 
subjected to a recall.  
Patient’s own medication: Guidelines should be established for the use of the 
patient’s “own medication” while at the hospital. Under limited and unusual 
circumstances the patient's own medication may be used according to 
guidelines established. 
Drug Samples: The use of drug samples shall be eliminated to the extent 
possible. If samples use is permitted, the pharmacy must control the samples 
to ensure proper storage, maintenance of records and product integrity. 
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Controlled drugs: Accountability procedures shall exist to ensure their 
control.  
Medication storage area inspection: All medication storage areas shall be 
inspected routinely to ensure absence of expired items. Storage arrangements 
that might contribute to medication errors are identified and corrected. 
Floor stock/ward stock: Floor stocks shall be limited to emergency 
medications and safely used items (e.g., mouthwashes, disinfectants and 
antiseptic solutions). The potential for medication error and adverse effect 
should be considered for floor stock medications. 
Disaster plan: A disaster plan shall exist for providing pharmaceutical 
services in case of a disaster event. 
 
Standard 5- Facilities, equipment and information resources 
Adequate space and equipment shall be available for professional and 
administrative functions to ensure optimal performance, smooth, efficient 
work flow and quality patient care. The resources must be located in areas that 
facilitate the provision of services and must be integrated with the hospital’s 
communication or delivery systems. Facilities shall be constructed, arranged 
and equipped to promote safe and efficient work and to avoid deterioration of 
medications. The minimum standard for facilities, equipment and information 
resources shall observe the followings: 
Medication storage areas: Facilities shall exist to enable the storage and 
preparation of medications under proper conditions of sanitation, ventilation, 
temperatures, light, moisture, segregation and security to ensure medication 
integrity and personnel safety. 
Packaging and compounding area: Designated space and equipment for 
packaging and compounding of medications and sterile products shall exist. 
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There should be a clean work environment that promotes efficiency and 
minimize potential for contamination of the products.  
Drug information: Adequate space and resources shall be available to 
facilitate provision of drug information.  
Consultation space: In outpatient dispensing areas, a private area for patient 
counseling and education shall exist. 
Office and meeting space: Offices shall be available for administrative 
activities. Meeting areas shall be available for administrative, educational and 
training activities. 
 
Standard 6- Investigational medications  
The pharmacist shall ensure that the policies and procedures for the safe 
and proper use of investigational medications are developed and followed and 
responsible for overseeing the distribution and control of all investigational 
medications.  
 
1.2.2 PRACICE SETTING AND MANAGEMENT 
1.2.2.1 Recruitment and selection of pharmacy personnel 
These guidelines are intended to assist pharmacy managers in the 
recruitment and selection of qualified employees.  
Recruitment 
Position/job descriptions 
Well-developed job descriptions are important tools for addressing 
many personnel issues. They are often used to establish salary ranges, define 
performance expectations, and write performance evaluations, but they can 
also be crucial tools in a successful recruitment effort. (Brown, 2001a) 
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The position description should contain detailed information on the 
knowledge, skills, experience, and abilities that an acceptable candidate 
should possess (ASHP, 2003). The following information may be included in 
a position description: 
• Position title and position control number (if applicable), 
• Duties, essential job functions, and responsibilities of the position, 
• Education, training, experience, and licensure required, 
• Knowledge, skills, and abilities required to perform assigned duties, 
• Reporting relationships, 
• Pay grade and salary range (optional), 
• Education and training required to maintain competence 
Selection 
A successful interview process is one that matches the best available 
candidate with a specific position (ASHP, 2003). 
Individual interview (one interviewer and one interviewee.)  
Advantages: Individual interviews offer simplicity, ease of scheduling, 
and consistency. Because they are less intimidating to the candidate than 
group interviews, individual interviews may allow the interviewer to more 
accurately evaluate the candidate and provide the candidate with more 
opportunities to ask questions. 
Disadvantage: It does not allow for multiple viewpoints and therefore 
increases the chance that something will be overlooked. 
Team interview (group of interviewers).  
Members of the team may interview the candidate individually and then 
pool their results or they may interview the candidate as a group.  
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Advantage: More individuals participated in the process of analyzing a 
candidate’s qualifications. Team interviews foster the ideal of teamwork, and 
the involved employees share responsibility for the success or failure of the 
person hired. They also provide an opportunity to observe the candidate’s 
ability to interact with groups, which may be important if the position will 
require that type of skills. 
Disadvantages: Extra time consumed to train the team and conduct 
interviews and the intimidating effect it may have on candidates.  
 
1.2.2.2 Quality improvement/Performance improvement plan 
To establish a performance improvement plan for the Pharmacy 
Department, therefore providing a systematic and continuous method for 
measuring, assessing and improving the quality of pharmacy services. 
Roles and responsibilities (Brown, 2001b) 
Heads of pharmacy services are responsible for the overall operation of 
their department and for the measurement, assessment and continuous 
improvement of the department’s performance. The department leader is 
responsible for motivating the staff to improve their performance 
continuously. He (she) reviews and approves department quality improvement 
plan, supports teamwork approach and inter-department interaction, 
participate in quality improvement educational process and provides resources 
needed for quality improvement. 
Pharmacy Staff 
All staff members of the Pharmacy have the ultimate responsibility 
of achieving quality. They will be involved in interdepartmental and across 
board performance improvement educational sessions and will participate 
in PI projects to ensure the delivery of the highest quality patient care. 
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Performance improvement will be selected and formed according to the 
identified opportunity for improvement. Each team will have a team 
leader, team facilitator, and at least two members. 
Quality Improvement Designee (if applicable), otherwise Pharmacy 
Manager resumes the following responsibilities: 
• Coordinates, develops and implements the departmental PI plan 
• Assists the PI teams and ensures documentation of the projects 
• Coordinates PI educational process for pharmacy staff 
Performance measurement 
The department shall collect data systematically for both improvement 
priorities and continuing measurement. The process of data collection 
activities is often collaborative and interdisciplinary in nature. 
 Measurement and data collection is the foundation of all performance 
improvement activities and organization functions. To measure performance, 
the pharmacy department collects data on the processes and outcomes, high-
risk, high-volume and problem prone processes, patients needs, expectations 
and department specific patient satisfaction questionnaires and/or surveys, 
infection control activities, safety of the care environment and risk 
management issues and findings (Brown, 2001c and Shane, 2006). 
Data collection on medications 
Medication is a common and important component in patient care.  
Medication use is measured on an ongoing basis. 
Most medications are associated with potentially serious risks, such as 
common short-term side effects, idiosyncratic responses, medication 
interactions, food-medication interactions and side effects from long-term use 
and toxic levels. Consequently, if medication is not administered when 
needed, a patient may not achieve the full benefits of therapy. If it is 
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administered when not needed, the patient may experience unnecessary risks. 
And when administered incorrectly, existing risks may be magnified and new 
risks introduced.  For these reasons, medication use historically has been 
given special attention in measuring and improving diagnostic and therapeutic 
interventions. 
Due to the fact that a hospital uses so many medications, priorities for 
ongoing assessment have been developed. These priorities are based upon the  
number of patients taking a medication, balancing of risk with therapeutic 
potential, medications known or suspected to be problem prone and 
therapeutic effectiveness (i.e. use of antibiotics to treat pneumonia) (Brown, 
2001d; Fong, 2005 and Shane, 2006). 
The following medication processes carried out by the organization are 
measured, though not necessarily at the same time: Prescribing or ordering, 
preparing and dispensing, administrating, monitoring the effects and side 
effects on patients and over time. The hospital includes these four processes in 
its data collection activities. 
Performance measures 
These can be summarized as: Medication errors; wrong drug, dosage, time, 
route or rate of administration, wrong patient, omission, duplication, or 
administration without an order, adverse reaction to medication, medication 
order filled incorrectly, controlled substance missing and/or incorrect count, 
occurrences that have an adverse result on a patient, equipment 
breakage/failure that has an adverse result on a patient, equipment not 
available, expired, recalled or otherwise unusable drug dispensed, formulary 
management, labeling of drugs, education of patients and family, drug recall 
measures, prevention and control of infection, research investigational drugs, 
ambulatory pharmacy services, patient outcomes; long and short range 
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continuing education, technical quality control activities and adverse drug 
reactions 
 
1.2.2.3 Pharmacy quality improvement indicators  
Quality Improvement indicators are quantitative tools expressed as, 
rate, ratio or percentage to evaluate the performance and compare it with a 
target or standard. QI should be developed and measured routinely to provide 
a continuous quality improvement measurement of the medication use system, 
processes and procedures. The data collection is based on high-risk, high-
volume and problem prone processes. Here are examples for different types of 
indicators (Fong, 2005; Brown, 2001e; ASHP, 1991 and ASHP 1992) 
Rate based indicators 
Measure the degree of occurrence of an event either in same population 
(same denominators) or different population (different denominators). e.g. 
asthmatic patients educated on the use of inhalers/ total number of asthmatic 
patients and missing medications/total number pharmacists. 
Sentinel event 
Measures all serious events that require further analysis and 
investigation in its occurrence. e.g. death as a result of a medication error. 
Structure indicators 
Measure the capability of the system to provide care and focus on 
resources, qualifications, equipments or space. e.g. hours of operations and 
ratio of pharmacists to technicians. 
Process indicators 
Measure the steps of providing care procedure, could be clinical, 
supportive or administrative. e.g. interpretation of a medication order, first 
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dose dispensed agrees with order and prepackaging of bulk medications into 
unit of use. 
Outcome indicators 
Measures the outcome of a process of care; could be clinical, or 
functional. e.g. patients receiving vancomycin infusion over a period less than 
45 minutes who experience red-neck syndrome and patient satisfaction. 
Process/operational indicators 
Covers all processes and operations related to pharmacy practice and 
medication use. e.g. appropriateness of outpatient prescriptions, outpatient 
prescriptions are correctly filled and labeled, narcotic drugs dispensing 
complies with narcotic laws and rules, parenteral solutions correct in dose and 
admixtures, medication error reporting, verification of physician's order by the 
pharmacist, adverse drug reaction (ADR) reporting and monitoring, 
code/emergency boxes accurately filled and available, patient cassettes filled 
accurately and pharmacy dispensing complies with rational therapy. 
In summary not all quality improvement indicators provided should be 
measured. Pharmacy should select the quality improvement indicators to be 
measured according to their scope of services and the feasibility of continuous 
measuring. Collection is usually carried on monthly basis according to the 
developed quality improvement measuring profile. If the quality improvement 
indicator goal failed for 3 consecutive months a Root Cause Analysis (RCA) 
is required to figure failure causes. 
1.2.2.4 Policies and procedures guidelines manual  
The Pharmacy Policy and Procedure Manual serves as a comprehensive 
reference for pharmacy staff regarding operational, clinical and administrative 
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policies and procedures endorsed by Pharmacy Management and Hospital 
Administration (Manitoba, 2004 and ASHP, 1995).  
 
Format, approval, review, and maintenance 
A standardized template is used for all pharmacy policies. Pharmacy 
policies and procedures are reviewed, at a minimum every 2 years or 
whenever practice and/or standards change. Revisions are made as 
appropriate. All unit managers are responsible for making sure all of their 
employees know, understand, and are in compliance with new policies and 
procedures as they are implemented. Signed copies of pharmacy policies are 
maintained in the pharmacy working areas and offices.  
Proposed policies  
Since most Hospital Pharmacies in Sudan do not have up-to-date 
policies and procedures covering their operational functions, the present study 
provides a proposal of the internationally agreed upon policies. The proposed 
policies cover the Joint Commission International (JCI) Medication 
Management and Use (MMU) mandatory policies (JCIA, 2007; Manitoba, 
2004 and ASHP, 1995), in addition to other policies required for practice 
setting and management. Hospitals with less scope of service in Sudan, can 
select policies that match with their practices. 
General departmental policies: These can be summarized as: Code of ethics, 
pharmacy practice, Continuing Education, pharmacy occupational health and 
safety, pharmacy disaster plan, pharmacy performance improvements plan, 
staffing plan, scope of services and pharmacy and therapeutic committee 
Formulary system: Comprise the formulary and non – formulary processes 
and drug samples. 
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Inventory management: Regulates the drug procurement and storage control, 
medication security, storage of flammable materials, expired medications, 
medication recall and borrow and loan. 
 
Drug distribution service: Is divided into 4 categories:  
1. Medication order processing: This deals with prescribing medications 
(general practices), general guidelines for inpatient medication orders, 
prescriber’s signatures, pharmacist order verification, automatic stop 
orders and verbal or telephone medications orders.  
2. Narcotic and controlled drug management: Govern narcotic and 
controlled medications, destruction of narcotic and controlled 
medications, resolving a narcotic or controlled drug discrepancy, 
Pharmacy narcotic room counts, storage of narcotic and controlled drugs, 
outpatient narcotic prescribing and dispensing and controlled drug 
prescribing and dispensing. 
3. Drug distribution: Describes policies regarding repackaging oral solids 
and liquids in single unit and unit dose packages, extemporaneous 
compounding of pharmaceuticals, unit dose drugs, unit dose patient 
medication profiles, order entry, patient medications profiles, storage of 
medications outside the pharmacy, availability of concentrated potassium 
chloride for injection, emergency medications, labeling standards, 
discharge medications, light sensitive medications, investigational drugs 
used in clinical  research, radiographic medications & radiographic 
contrast media, destruction of expired medications, refrigerated drugs & 
vaccines, pharmacy courier service, return of medication to pharmacy 
from nursing units and ward stock medications 
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4. Drug administration: Policies govern medication administration, self – 
medications, patient own medications, uniform drug administration, use 
of multi dose vials and standard medication administration times 
IV Admixture Service: Describes policies regarding sterile admixture service, 
intravenous drug administration, returned, unused iv admixtures processing, 
aseptic technique, handling of cytotoxic drugs, pharmacy infection control and 
sterile technique, chemotherapy spill, iv room personnel: validation, education 
and training and dating of opened containers 
Clinical pharmacy services: Govern pharmacist assessments of patients, adult 
parenteral nutrition support, pediatric and neonatal tpn, drug food interactions, 
anticoagulation monitoring protocol, therapeutic drug monitoring and poison 
control information. 
Education: This deals with patient drug information leaflet, patient teaching 
and patient education of discharge prescriptions. 
Quality Improvement: Describes policies regarding promotion of a safe 
medication use, medication use evaluation, medication use and management  
process, adverse drug reaction reporting, medication error reporting, do not 
use abbreviations, look alike sound alike medications and high alert 
medications. 
Orientation: Provides directions and procedures for orientation of nurses to 
pharmacy services, general orientation program/new arrivals, inpatient 
pharmacy orientation program, outpatient pharmacy orientation and clinical 
pharmacy orientation. 
Outpatient pharmacy: Describes policies regarding outpatient prescription 
processing and counseling, outpatient medication labeling, outpatient 
counseling, discharge process and uncollected prescriptions. 
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1.2.3 DRUG INFORMATION AND EDUCATION 
1.2.3.1 Provision of drug information 
Provision of drug information is a fundamental professional responsibly 
of pharmacists in hospitals. The goal of providing evidence supported 
information should be to enhance the quality of patient care and improve 
patient outcomes (Troutman, 1994 and Manitoba, 2004). 
The pharmacist providing drug information must be able to perceive 
and evaluate the drug information needs of patients and families, health care 
professionals and other personnel. Also he/she must be able to use systemic 
approach to address drug information needs by searching, retrieving and 
evaluating the literature, then appropriately communicating and applying the 
information to the patient situation.  
1.2.3.2 Drug information functions/activities 
The following activities are often performed by drug information 
center. (Rosenberg et al., 1995 and Manitoba, 2004) 
• Providing drug information to perceive and evaluate the drug 
information needs of patients and families, health care professionals 
and other personnel. 
• Establishing and maintaining a formulary 
• Coordinating of reporting of medications misadventuring e.g. adverse 
drug reaction. 
• Development of medication use evaluations and drug monographs. 
• Educating health care providers about medication use policies and 
procedures. 
• Publishing newsletters to educate patients and families, health care 
professionals and other personnel. 
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• Coordinating investigational drug services. 
• Providing continuing education to the health care professionals.  
• Educating pharmacy students and residents. 
• Developing and maintaining an active research program. 
1.2.3.3 Handling of drug information requests 
The pharmacist must objectively evaluate and apply the retrieved 
literature to a particular patient or situation (Galt, 1994; Smith, 1995 and Galt 
et al, 1995). The drug information requests can be handled as follows: 
• Determine the background of the requester 
• Identify needs. This will helps in optimizing the search process and 
assessing the urgency for a response.   
• Classify requests as patient-specific or not (general) and by type of 
question to aid in assessing the situation and selecting resources. 
Most DI requests fall into the following categories: Dug 
identification/availability, adverse drug reactions, compatibility, drug 
administration, drug interactions, pharmacokinetics, therapeutic use/efficacy, 
safety in pregnancy and nursing, toxicity and poisoning.  
Patient-specific information is age, weight, sex and race, concurrent 
medications and disease states, known allergies/adverse drug reactions and 
renal/liver function. 
• Search and formulate answer in a logical sequence with supporting 
references. 
• Provide a response by written, oral consultation or both as 
appropriate. 
• Perform a follow-up, summarize answer 
• Document the request, information sources, response and follow-up   
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1.2.3.4 Drug information resources and reference materials 
It is the responsibility of the pharmacist to ensure that up-to-date 
resources are available. This list of recommended references includes those 
sources that commonly provide useful drug information however, review of 
additional specialty journals or other sources may be required. 
Texts are: 
• American Hospital Formulary Service Drug Information. 
• Facts and Comparisons. 
• Martindale-The Extra Pharmacopoeia. 
• Physicians’ Desk Reference. 
• The Pharmacological Basis of Therapeutics. 
• British National Formulary 
Periodicals and abstracting systems are: the American Journal of Hospital 
Pharmacy, Annals of Internal Medicine, Archives of Internal Medicine, 
Clinical Pharmacology and Therapeutics, Clinical Pharmacy, Drug Therapy, 
Drugdex, Hospital Formulary, Hospital Therapy, Journal of the American 
Medical Association, The Lancet, Medical Letter on Drugs and Therapeutics, 
New England Journal of Medicine, Pharmacotherapy, Annals of 
Pharmacotherapy. Computers can be valuable in provision of drug information 
(Dasta et al., 1992 and McEvoy, 2005). 
Information management databases are software for MUE, documentation 
of questions and responses and preparation of reports of adverse events. 
Information retrieval sources  
• Bibliographic databases e.g. Medline 
• Full-text databases e.g. drug information Full text. (Baker et al., 
1994). 
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1.2.3.5 Patient education and counseling 
The purpose of these guidelines is to help pharmacists provide effective 
patient education and counseling (ASHP, 1997 and Manitoba, 2004). In 
pharmaceutical care, pharmacists should encourage patients to seek education 
and counseling and should eliminate barriers to providing it, seek 
opportunities to participate in hospital patient-education programs and to 
support the educational efforts of other health care team members, and 
collaborate with other health care team members, as appropriate, to determine 
what specific information and counseling are required in each patient care 
situation.  
Environment 
Education and counseling should take place in a comfortable, 
confidential, and safe environment (ASHP, 1997 and Manitoba, 2004). 
Education and counseling are most effective when conducted in a room 
or space that ensures privacy and opportunity to engage in confidential 
communication. If such an isolated space is not available, a common area can 
be restructured to maximize privacy from other patients or staff. Patients, 
including those who are disabled, should have easy access and seating. Space 
and seating should be adequate for family members or caregivers. The design 
and placement of desks and counters should minimize barriers to 
communication. The environment should be equipped with appropriate 
learning aids, e.g., graphics, anatomical models, medication administration 
devices, written material, and audiovisual resources. 
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Figure 1.1. Education and counseling process 
 
Process Steps 
Steps in the patient education and counseling process will vary 
according to the hospital policies and procedures, environment, and practice 
setting. Generally, the following steps are appropriate: (ASHP, 1997), (Figure 
1.1) 
1. Establish caring relationships with patients as appropriate to the 
practice setting and stage in the patient’s health care management. 
Introduce yourself as a pharmacist, explain the purpose and expected 
length of the sessions and obtain the patient’s agreement to 
participate. 
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2. Assess the patient’s knowledge about his or her health problems and 
medications, physical and mental capability to use the medications 
appropriately, and attitude toward the health problems and 
medications. Ask open-ended questions about each medication’s 
purpose and what the patient expects, and ask the patient to describe 
or show how he or she will use the medication. Patients returning for 
refill medications should be asked to describe or show how they have 
been using their medications. They should also be asked to describe 
any problems, concerns, or uncertainties they are experiencing with 
their medications. 
3. Provide information orally and use visual aids or demonstrations to 
fill patients’ gaps in knowledge and understanding. Open the 
medication containers to show patients the colors, sizes, shapes and 
markings on oral solids. For oral liquids and injectables, show patients 
the dosage marks on measuring devices. Demonstrate the assembly 
and use of administration devices such as nasal and oral inhalers. As a 
supplement to face-to-face oral communication, provide written 
handouts to help the patient recall the information. 
4.Verify patients’ knowledge and understanding of medication use. Ask 
patients to describe or show how they will use their medications and 
identify their effects. Observe patients’ medication-use capability and 
accuracy and attitudes toward following their pharmacotherapeutic 
regimens and monitoring plans. 
30 
 
Content 
ASHP (1997) recommended that the content of an education and 
counseling session may include the following information: 
• The medication’s trade name, generic name, common synonym, or 
other descriptive name(s) and, when appropriate, its therapeutic class 
and efficacy. 
• The medication’s use and expected benefits and action. This may 
include whether the medication is intended to cure a disease, eliminate 
or reduce symptoms, arrest or slow the disease process, or prevent the 
disease or a symptom. 
• The medications expected onset of action and what to do if the 
action does not occur. The medication’s route, dosage form, dosage, 
and administration schedule (including duration of therapy). 
• Directions for preparing and using or administering the medication. 
This may include adaptation to fit patients’ lifestyles or work 
environments. 
• Action to be taken in case of a missed dose. 
• Potential common and severe adverse effects that may occur, actions 
to prevent or minimize their occurrence, and actions to take if they 
occur, including notifying the prescriber, pharmacist, or other health 
care provider. 
• Techniques for self-monitoring of the pharmacotherapy. 
• Potential drug–drug (including nonprescription), drug–food, and 
drug–disease interactions or contraindications. 
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• The medication’s relationships to radiologic and laboratory 
procedures (e.g., timing of doses and potential interferences with 
interpretation of results). 
• Instructions for 24-hour access to a pharmacist. 
• Proper storage of the medication. 
• Proper disposal of contaminated or discontinued medications and 
used administration devices. 
• Any other information unique to an individual patient or medication. 
 
Documentation 
Pharmacists should document education and counseling in the patient 
medical record as consistent with the patients’ care plan and the hospital 
policies and procedures. When pharmacists do not have access to patients’ 
medical records, education and counseling may be documented in the 
pharmacy’s patient profiles, on the medication order or prescription form, or 
on a specially designed counseling record:  
1. The content should be documented as appropriate (for example, 
counseling about food–drug interactions). 
2. All documentation should be safeguarded to respect patient 
confidentiality and privacy. 
Examples of patient education and counseling include oncology and palliative 
care, HIV/AIDS, TB, STIS and Diabetic patient.  
 
In summary, patient education and counseling is a direct patient care 
function using the pharmaceutical care model to be provided. Depending on 
the hospital’s policies and procedures, its use of protocols or clinical care 
plans, and the privileges for the health care providers, pharmacists may also 
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have disease management roles and responsibilities for specified categories of 
patients. This expands pharmacists’ relationships with patients and the content 
of education and counseling sessions. Due to the absence of structured clinical 
activities and pharmaceutical care planning in Sudan, this project may provide 
a head start for pharmacists, not only in hospitals but also in community 
pharmacies, to consider. 
 
1.2.4 DRUG DISTRIBUTIONS AND CONTROL 
The primary function of the hospital pharmacy is the management of 
medications in the hospital, including procurement, storage, compounding, 
preparing, dispensing and distribution of those medications (ASHP, 1996 and 
(Manitoba, 2004). 
 
1.2.4.1 Methods of drug distribution 
The distribution of medications by hospital pharmacy is usually carried 
by the following methods: 
I. Ward stock system (conventional floor stock system)  
A given amount of medications are stored in medications rooms at 
nursing units and restocked by the pharmacy staff. Dispensing, calculations of 
doses and administration are done by nurses. It is not widely use due to lack of 
control, high incidence of medication errors and waste of medications 
II. Unit dose drug distribution system 
The unit dose system of medication distribution is a pharmacy- 
coordinated method of dispensing and controlling medications in organized 
health-care settings. 
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Practice description 
A unit dose (single dose) of packed medication is prepared by 
pharmacy. The unit doses covering 24 hours are loaded into a drawer 
designated for specific patient. Group’s patient drawers are loaded in the 
cassette of unit dose cart. The cassettes for specific nursing units are 
exchanged on a daily basis at constant designated time. 
The unit dose system may differ in form, depending on the specific 
needs of the organization. However, the following distinctive elements are 
basic to all unit dose systems: (ASHP, 1989 and ASHP, 1983). First, 
medications are contained in single unit packages. Second, medications 
dispensed in a ready-to-administer form as possible. Third, for most 
medications, not more than a 24-hour supply of doses is delivered to or 
available at the patient-care area at any time. Finally, patient medication 
profile is concurrently maintained in the pharmacy for each patient. 
 
Advantages  
Studies concerning unit dose drug distribution systems have been 
published over the past several decades (Murrary and Shojania, 2001). These 
studies indicate that unit dose systems, with respect to other drug distribution 
methods, are safer for the patient. They are more efficient and economical for 
the organization and more effective method of utilizing professional resources. 
More specifically, the advantages of unit dose systems over alternative 
distribution procedures (ward stock system) are:  
• Reduction in the incidence of medication errors. 
• Decrease in the total cost of medication-related activities. 
• More efficient usage of pharmacy and nursing personnel, allowing for 
more direct patient-care involvement by pharmacists and nurses. 
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• Improved overall drug control and drug use monitoring. 
• More accurate patient billings for drugs. 
• Greater control by the pharmacist over pharmacy workload patterns 
and staff scheduling. 
• A reduction in the size of drug inventories located in patient-care 
areas. 
• Greater adaptability to computerized and automated procedures 
(ASHP, 1989 and Manitoba, 2004). 
 
III. Combination system 
A combination of a unit dose distribution system and ward stock may 
be used. The ward stocks are usually limited to medications of high usage 
such as antacids, cough syrups, etc, while the majority of specific drugs are 
distributed form the pharmacy by the unit dose distribution system. 
 
IV. Intravenous admixtures system 
The pharmacy staff mixes and prepares all sterile parentral medications 
(e.g., admixed fluid bags, mini-bags, syringes and irrigations) using aseptic, 
sterile technique in a laminar flow hood. 
Advantages 
Centralizing all sterile compounding procedures within the pharmacy 
ensures (Manitoba, 2004; Kastango, 2005 and USP-797, 2005). 
1) Quality: where pharmaceutical appropriateness of the preparation and 
the product is free from particulate, microbial or pyrogenic 
contaminants is granted. 
2) Control: Where correct preparation, labeling with administration rate, 
correct storage and stability are ensured.  
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3) Also it free nurses from such preparations allowing them to have 
more time for patient care. 
In Sudan, the unit dose and intravenous admixture systems do not exist. 
Drug distribution and control by pharmacy is one of the minimum standards 
required in a hospital pharmacy. Failure to do so will compromise the 
pharmaceutical care.  
Unit dose and intravenous admixture systems are widely used and 
recommended as safe methods of drug distribution and control due to their 
advantages. For these reasons all parentral drug admixtures should be 
prepared by pharmacists under sterile conditions, thus reducing patient 
infections, free nurses from such preparations allowing them more time to 
patient care. This program would need only few staff, but it would require 
space and equipment. 
A unit dose system is needed to control the drug distribution. This 
system reduces drug wastage and saves nursing time. It increases the 
assurance that the correct medication has been given to the correct patient in 
the correct dosage. It also allows checking on potential drug interactions. This 
system leads to huge financial saving, although it needs more manpower 
(Murrary and Shojania, 2001; ASHP, 1989 and Manitoba, 2004). As has been 
mentioned above, none of these recommended services are currently applied 
in Sudan. Therefore this study was designed to shed light on the possibility of 
introduction of these services at any level and at any hospital type. 
1.2.4.2 Unit dose system implementation 
For reasons of safety and economy, the preferred method to distribute 
medications at hospitals is the unit dose system; although the implementation 
is costly but on the long run it will drastically decrease the cost of medication 
use (Murrary and Shojania, 2001; ASHP, 1989 and Manitoba, 2004). 
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Requirements 
Space Adequate space is required for the unit doses system functions, these 
areas are: 
Unit dose central working area/order entry station 
An order entry station will range in size from 50 to 150 square feet (15 
to 45 square meters) based on the size of the hospital and the amount of 
electronic equipment and staff requirements (Herman Miller, 1999a). 
 
Unit dose cassette filling area/Picking area 
The filling area will range from 55 to 90 square feet (16.5 to 27 square 
meters) based on the size of the hospital and the number of formulary drugs. 
Extra space is desirable for the cart storage (Herman Miller, 1999b). 
Pre-pack room 
Space is required to accommodate the unit dose tablet manufacturing 
machine, unit dose liquid dispensing machine and the storage shelves. Space 
depends on the size of the hospital and the number of formulary drugs. The 
compounding area can be included within the pre-pack room. 
Equipment 
The unit dose central working area requires: 
Personal computers for physician order entry and to maintain an electronic 
pharmacy patient profile. 
Unit dose label printers for printing unit dose pre-packs labels of the first 
doses. 
Heavy duty laser printer for printing patient profiles, cassette filling profiles, 
filling update lists and other patient related reports.  
A4 printer for printing drug information inquires and non-dispensing reports 
and requests. 
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Medication refrigerators for proper and safe storage of refrigerated 
medications.  
The unit dose cassette filling area requires: 
Unit dose cassettes for loading the unit dose medications in patient 
medication drawers. 
Large trolleys for unit dose cassettes to store and transport the unit dose 
carts. 
Personal computer to generate the cassettes fill lists and updates. 
Unit dose label printer to print the cassettes fills label patches.  
The pre-pack room requires: 
Unit dose tablet manufacturing machine for manufacturing the bulk 
medications into unit dose strips. 
Unit dose liquid dispensing machine to prepare the oral liquid into ready-to 
administer form (Pedi-pods). 
 
1.2.4.3 Decentralization of pharmacy services 
Pharmacy satellites 
Satellites are mini-inpatient pharmacies, usually a room range in size 
from 35-75 square meters exist in any patient care units (Herman Miller, 
1999c). Commonly placed in critical care areas, emergency department, 
surgical units, pediatrics, medical and chemotherapy units.  
Equipped with: 
• Shelves for medications storage 
• One to two personal computers for order entry with unit dose 
and IV label printer 
• Laminar flow hood for intravenous medications preparation 
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• Medication refrigerator for proper and safe storage of 
refrigerated medications. 
Advantages 
The satellites represent the idea of the direct patient care, improve 
communication with other health care provider and ensure the availability of 
pharmacists at the patient care units. They reduce the delivery time for 
medications. Pharmacists are available at nursing unit to provide drug 
information to the physicians and nurses. More involvement of pharmacists in 
clinical therapy of the patients and participation in medical rounds. 
Generally availability of pharmacy services and pharmacists at the 
nursing units supports the vision of direct patient care. 
 
Pharmacy working stations 
A station to provide pharmacy services within the nursing unit; a small 
room or desk with one personal computer is required for order entry. The 
labels for the entered medications orders are routed to the pharmacy prepared 
from central pharmacy and delivered to the nursing units. 
Working stations allow pharmacists to interact more with other health 
care providers at the nursing unit and have more time to perform clinical 
functions. Also it requires less space and equipment. It is a suitable alternative 
for satellites when cost is an issue.  
In Sudan, the unit dose system as a drug distribution system does not 
exist. No structured clinical activities and direct patient care are provided. 
Pharmacy working stations are the best opportunity to control the drug 
distribution by pharmacy and allow pharmacists to interact with physicians, 
nurses at the nursing units and have more time for clinical activities. 
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Flow of medications orders and medications 
Medication orders are always initiated by physician in a written form. 
The typical path or flow of a written medication order and the medication to, 
through and from the pharmacy is described in figure 1.2. 
 
 
 
Figure 1.2. Flow of medication orders and medications. 
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Flow chart for the unit dose cassettes filling 
The process of filling the daily routine unit dose medications for the 
patients is illustrated in figure 1.3. 
 
 
 
Figure 1.3. Flow chart for unit dose cassette filling. 
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Flow chart of the IV Admixture preparation 
The process of preparing the daily IV Admixture medications for the 
patients is illustrated in figure 1.4. 
 
 
 
Figure 1.4. Flow chart for IV Admixture preparation. 
 
1.2.4.4 Comprehensive IV admixture program   
All parentral drug admixtures should be prepared by pharmacists under 
sterile conditions, thus reducing patient infections, free nurses from such 
preparations allowing them more time to patient care. (USP-797, 2005 and 
Manitoba, 2004). 
1.2.4.4.1 IV room (clean room) requirements 
Space  
A closed room with positive pressure for isolation and cleanliness in 
preventing contamination is required (Kastango, 2005 and USP-797, 2005). 
The controlled area should meet the standards of a class 10,000 clean room 
(ISO class 7). A positive air pressure relative to adjacent pharmacy areas is 
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required. To allow proper cleaning and disinfection, walls, floors, and ceilings 
in the controlled area should be nonporous. To help reduce the number of 
particles in the controlled area, an adjacent support area (e.g., anteroom) 
should be provided.  
The size of the IV room will vary based on of the size of the hospital, 
types of medications being added to the fluids and the number of hoods 
needed.  
The IV room will range in size from 160 to 500 square feet (48 to 150 
square meters) (Herman Miller, 1999d) 
The floors should be nonporous and washable to enable regular disinfection. 
e.g. seamless vinyl sheet.  
The Ceiling should be nonporous e.g. epoxy-painted drywall or ceiling tile 
with aluminum T – bar grid.  
The walls should be nonporous and washable. e.g. monolithic vinyl, fiberglass 
reinforced polyester, epoxy-painted drywall or melamine panel.  
The doors should be stainless steel or anodized aluminum.  
Windows should be tempered safety glass with stainless steel or anodized 
aluminum frame. (Kastango, 2005) 
Equipment 
The equipment required for the IV Admixture room are: 
Laminar flow hoods for preparation of IV admixtures under aseptic 
technique. 
Pass through fridge/2-sided refrigerator used to store the finished admixed 
preparations and deliver from outside (closed clean room). 
Medication refrigerator for proper and safe storage of refrigerated injectable 
medications. 
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Personal computers to maintain intravenous patient profile and to run 
intravenous fill labels and updates.  
IV label printer to print the intravenous label patches 
 
1.2.4.4.2 Aseptic technique 
Aseptic technique is a set of specific practices and procedures 
performed under carefully controlled conditions with the goal of minimizing 
contamination by pathogens. 
The goals of aseptic technique are to protect the patient from infection 
and to prevent the spread of pathogens. Nosocomial (hospital-acquired) 
infections are responsible for longer hospital stays and increased costs to the 
patient and hospital. Aseptic technique is vital in reducing the morbidity and 
mortality associated with these infections. (ASHP, 2000 and USP-797, 2005) 
 
1.2.4.4.3 Risk-Level Classification Sterile products are grouped into three 
levels of risk to the patient, increasing from least (level 1) to greatest (level 3) 
potential risk based on the danger of exposing multiple patients to inaccurate 
ingredients or pathogens and based on microbial growth factors influenced by 
product storage time, temperature and product ability to support microbial 
growth, surface and time exposure of critical sites, and microbial bioload in 
the environment. When circumstances make risk-level assignment unclear, 
guidelines for the higher risk level should prevail (Table 1.1). (ASHP, 200 and 
USP-797, 2005). 
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Table 1.1. Risk level Classification 
 
 
Class Low Risk – Level 1 Medium Risk - Level 2 High Risk - Level 3 
 Description “Sterile to Sterile” 
non “batch” transfers 
One to One transfer 
One to Many  
or Many to One  
More than 3 components 
Non-sterile to sterile 
compounding 
 Examples Reconstituting 1gm 
Cefazolin and 
injecting the contents 
into a IVPB 
Reconstituting 10gm 
Nafcillin or Vancomycin and 
transferring to many IVPB’s 
TPN=Many to One 
Alum bladder 
irrigation 
 
1.2.4.4.4 Personnel education, training, and evaluation 
Training is the most important factor in ensuring the quality of sterile 
products (Kastango, 2005; ASHP, 2000 and USP-797, 2005).  
Pharmacy personnel preparing or dispensing sterile products must 
receive suitable didactic training and competency evaluation through 
demonstration, testing (written or practical), or both. Some aspects that should 
be included in training programs include: Aseptic technique and aseptic 
preparation procedures, clean room contamination factors, environmental 
monitoring, facilities, equipment, and supplies, sterile product calculations, 
terminology and compounding documentation, proper gowning and gloving 
technique and general conduct in the controlled area and quality assurance 
procedures. 
1.2.4.4.5 Stability  
All pharmacy-prepared sterile products should bear an appropriate 
expiration date (ASHP, 2000 and USP-797, 2005). The expiration date 
assigned should be based on currently available drug stability information and 
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sterility considerations. Sources of drug stability information include 
references e.g. AHFS Drug Information, Extended Stability for Parenteral 
Drugs, Handbook on Injectable Drugs, King Guide to Parenteral Admixtures, 
manufacturer recommendations, and reliable published research.  
1.2.4.4.6 End-product evaluation 
The final product should be inspected when preparation is completed 
and again when the product is dispensed (ASHP, 2000 and USP-797, 2005). 
This inspection includes an evaluation for container leaks, container integrity, 
solution cloudiness or phase separation, particulates in the solution, 
appropriate solution color, and solution volume. The responsible pharmacist 
should verify that the product was compounded accurately with the correct 
ingredients, quantities of each ingredient, containers, and reservoirs; different 
methods may be used for end-product verification (e.g., observation, 
calculation checks, and documented records). 
1.2.4.4.7 Infection control quality testing 
Settle plates or wipe samples can provide a simple but effective means 
of routinely monitoring airborne microbial contamination in controlled and 
critical areas. 
1.2.4.5 Medication safety 
The goal of medication safety program is to improve the quality of life 
for patients through excellence in patient care, education, research and 
community service to achieve zero medication associated injuries or harm 
(Goeltz, 2005). 
The objectives of this program include the establishment of a 
medication error reporting program that will foster safe medication practices 
in terms of prescribing, dispensing, administering and monitoring of therapy. 
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Identifying, designing, implementing and evaluating practices that eliminate 
or mitigate the effects of medication errors and system-related risks and 
hazards which compromise patient safety. It also focuses on educating health 
care providers, purchasers, patients, and policymakers about successful 
medication safety interventions and best practices. Dissemination of 
information to a variety of users on the causes of and successful interventions 
to identify, reduce, eliminate, or mitigate the effects of error and continuous 
monitoring and evaluation of threats to medication safety to ensure that a 
positive safety culture is maintained are among the objectives. In this aspect a 
medication safety team should be formed (Thurnbull, 2005; Lesar, 2005; May, 
2005 and Gordon, 2005) 
1.2.4.5.1 High-Alert Medications 
Most drugs have a wide safety margin; a few have a higher risk of 
causing harm when an error involving these agents occurs. These are referred 
to as “high-alert medications” (Pathways for medication safety, 2002). 
A list of high-alert medications is shown in Table 1.2. They are listed as 
individual medication or category (ISMP, 2005). Development of special 
procedures and written protocols for individual high-alert medications is 
required.  
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Table 1.2. High-alert medications list (ISMP, 2005).  
Adrenergic agents (e.g. epinephrine) Theophylline 
Dextrose Hypertonic > 20% Anesthetic agents (e.g. Propofol) 
Amiodarone IV Chemotherapeutic agents 
Digoxin IV Heparin 
Insulin Oral hypoglycemic agents 
Nitroprusside Warfarin 
Benzodiazepines Lidocaine IV 
IV Beta blockers Intravenous Magnesium 
Chloral hydrate Narcotics and opiates agents 
Hypertonic saline Neuromuscular blocking agents 
Potassium chloride injectable Potassium Phosphate 
Thrombolytics/fibrinolytics IV  Total parentral solutions 
 
1.2.4.5.2 Look alike & sound alike drugs (LASA) 
Drugs with similar names and similar appearance result in potential 
medication errors and patient harm (Pathways for medication safety, 2002). 
Actions to be taken 
• Develop a list of look alike and sound alike and updated annually 
(Appendix B). 
• Educate the health care providers about the hazard of look alike and 
sound alike drugs. 
• Look alike brands at the pharmacy must be identified. Move and 
reorganize the identified look-alike brands by storing them apart from 
each other and affix "colored coded labels" as a trigger alert. All 
patient care units should be fixed in the same manner. 
• POP – UP Alerts:  Screen alerts when entering a look alike/sound 
alike drugs in the pharmacy dispensing system    
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• TALLMAN LETTERING:  Similar names can de distinguished by 
tall man lettering.  
Example:  
Established name  Recommended name 
Acetohexamide  
Acetazolamide  
AcetaHEXAMIDE 
acetaZOLAMIDE  
 
1.2.4.5.3 Do not use dangerous abbreviations 
The use of dangerous abbreviations and dose designations can lead to 
medication errors such as: (Lesar, 2005 and Saborrn, 2005). 
• Administration via the wrong route 
• Unintended discontinuation of medications  
• Wrong strengths  
• Wrong dosages  
• Wrong drug 
The Pharmacy department requires developing a list of dangerous 
abbreviations (Appendix C) that should never be used and a policy prohibiting 
their use (JCI, 2007). Ensuring all pre-printed orders sets, protocols, clinical 
pathways and other document do not contain these abbreviations or improper 
use of decimal points. 
1.2.4.5.4 Adverse drug reporting (ADR) 
ADR is defined as "Any response to a drug that is noxious and 
unintended/ unexpected that occurs at doses used in humans for prophylaxis, 
diagnosis or therapy, excluding failure to accomplish the intended purpose" 
(Manasse and Thompson, 2005). 
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An ongoing ADR monitoring and reporting program can provide many 
benefits such as: Assessing the safety of drug therapies, especially new ones, 
educating health professionals and increase their level of awareness regarding 
adverse drug reactions, identifying and measuring trends and institute corrective 
actions designed to improve patient outcomes by minimizing potential adverse 
drug reactions and providing quality assurance/improvement initiatives in drug 
use (ASHP, 1995 and Manitoba, 2004). 
Procedures 
An unexpected or severe adverse drug reaction(s) may be reported 
initially by pharmacists, physicians, nurses or other health care providers 
using the ADR form (Appendix D). Pharmacist will assign a severity rating to 
each adverse drug reaction report according to the following classification 
scale (Naranjo et al, 1981): 
Minor An adverse drug reaction which requires no medical 
treatment or has no effect on continuation of therapy. 
Moderate An adverse drug reaction which results requires medical 
treatment or requires discontinuation of therapy. 
Severe An adverse drug reaction which is life-threatening, causes 
hospital admission, increases length of hospital stay or causes 
permanent injury or death. 
Adverse drug reaction reports will be further analyzed by method of 
reporting (spontaneous or retroactive medical record abstraction), type of 
adverse drug reaction (dose related or non-dose related) or time of occurrence 
(before admission or during hospitalization). 
In reporting of accumulated data, the Pharmacy will prepare a quarterly 
report of adverse drug events for presentation to their Pharmacy and 
Therapeutics Committee. The focus will be on identifying risk factors and 
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drug-related educational needs of the organization. The adverse drug reaction 
analysis may be the inspiration for medication use evaluation (MUE) 
programs and other quality assurance/improvement efforts. Drugs which are 
frequently encountered in adverse drug reaction analysis may be targeted for 
more intense evaluation or education.  
1.2.4.5.5 Medication error reporting 
The definition of a medication error, as provided by the National 
Coordinating Council for Medication Error Reporting and Prevention (NCC 
MERP), is: “...any preventable event that may cause or lead to inappropriate 
medication use or patient harm, while the medication is in the control of the 
health care professional, patient, or consumer.” (Manasse and Thompson, 
2005) 
Categorization of the medication Errors 
The NCC MERP categorize medication errors according to severity in 9 
categories as shown in Table 1.3. (Manasse and Thompson, 2005). 
Table 1.3.  NCC MERP categorization of medication errors  
Type of error  Result  
No Error  
Category A 
Circumstances or events that have a capacity to cause error 
Error, No Harm 
Category B 
An error occurred but the medication did not reach the patient. (An error of 
omission does reach the patient) 
Category C An error occurred that reached the patient but did not cause 
patient harm. 
Category D An error occurred that reached the patient and required monitoring to 
confirm that it resulted in no harm to the patient and/or required 
intervention to preclude harm 
Error, Harm 
Category E 
An error occurred that may have contributed to or resulted in temporary 
harm to the patient and required intervention  
Category F An error occurred that may have contributed to or resulted in 
temporary harm to the patient and required initial or prolonged 
hospitalization 
Category G An error occurred that may have contributed to or resulted in permanent 
patient harm  
Category H An error occurred that required intervention necessary to sustain life. 
Error, Death 
Category I 
An error occurred that may have contributed to or resulted in patient’s 
death 
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Categorization index  
The categorization index or thinking tree helps in correct figuring of the 
medication error category (Figure 1.5). (Manasse and Thompson, 2005) 
 
 
Figure 1.5.  Categorization index (Thinking Tree) 
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Hospital pharmacies are required to have a process for reporting and 
managing all medication errors and use the reported data as quality 
improvement issue to improve patient safety and therapeutic outcomes 
(Gragg, 2005; Cousins, 2005 and Lesar, 2005). In Sudan, most hospitals do 
not have an on-going program for monitoring reporting and preventing of 
medication errors. This study is intended to raise the attention of the 
appropriate hospital authorities to establish a mandatory program for 
medication error reporting. 
Implementation procedures  
The hospital administration shall require all departments and hospital 
personnel prescribing, dispensing, administering or monitoring medications to 
complete a medication error reporting form (Appendix E) manually or through 
the electronic medication error reporting system for all medication 
variances/errors issued by the pharmacy, or committed by any health care 
provider. 
Medication errors/variance data will be collected under the direction of 
the Hospital Pharmacy and Therapeutics Committee and treated as a quality 
control/quality improvement issues, prompting immediate corrective action 
for the patient, and appropriate review and evaluation of medication system 
procedures.  
 
1.2.4.6 Pharmacy informatics 
Pharmacists no longer need to be in their old traditional role, product-
focused dispensing. Automation can take over many of their duties. 
Automation can perform tasks that require tedious repetition, tiresome 
movement, intense concentration and tedious record keeping, and it will 
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replace many labor-intensive tasks, thus saving time for them to practice 
pharmaceutical care. 
Automated pharmacy systems are already in use throughout the 
pharmacy practice. Their primary use is for counting, packaging and labeling 
dosage forms for pharmacists and other health professionals to dispense and/or 
administer to patients while electronically documenting the process (Marvin, 
2005 and Kaushal and Bates, 2002). 
 
1.2.4.6.1 Pharmacy application system (software) 
For implementation of modern pharmacy distribution system (unit dose 
and Intravenous admixture) a computer pharmacy program is required. 
The software should provide a balanced combination of ordering, 
dispensing, administration, clinical and financial features that make it easy to 
manage medication use and support all pharmaceutical care practices. (Felkey, 
1997) 
The software should handle all types of orders and distribution systems: 
IV admixtures, unit-dosed medications, floor stock, and etc. to provide a 
"patient-centered" profile, rapid order entry, sophisticated clinical, drug 
utilization tools, and reports. (Marvin, 2005; Kaushal and Bates, 2002 and 
Talley, 1997). 
In Sudan, the hospital pharmacies are not computerized. 
Computerization will help in the implementation of the modern pharmacy 
distribution system, namely, unit dose and intravenous admixture. In addition, 
it will facilitate management of medication use and support all pharmaceutical 
care practices. 
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1.2.4.6.2 Computerized physician order entry (CPOE) 
Medication errors are the most common source of medical error and 
patient injury; these errors are caused by illegible handwriting 
One major strategy to improve safety and reduce adverse medication 
errors is computerized physician order entry (CPOE).  
CPOE can be defined as a complex process through which the physician 
enters patient care orders directly into a computerized healthcare information 
system. To achieve the expectation of reducing adverse drug events (ADEs), 
the clinical system must perform interactive clinical decision support 
functions, warning physicians of potential interactions, dosing irregularities, 
and inconsistencies with patient factors (e.g., allergies, pregnancy, etc.) 
(Bates, 2000; Kaushal and Bates, 2002; and Marvin, 2005). 
 
Benefits and advantages 
With CPOE, the physician types orders into a computer, and those 
orders are communicated electronically to the pharmacy. In an integrated 
system, the pharmacist then uses the pharmacy application of the system to 
review, verify and complete the order. This helps eliminate transcription errors 
at the nursing and pharmacy level. CPOE also decreases the communication 
burden between the pharmacist and the physician. (Kaushal and Bates, 2002 
and Marvin, 2005). Other benefits of a CPOE system include elimination of 
the need for handwritten orders, provision of a standardized format for 
medication orders, elimination of  errors arising from the use of prohibited 
abbreviations, identification of potential drug-drug and drug-food and drug-
disease interactions and ensurance that dose, form, and frequency are 
appropriate  
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Difficulties and barriers 
 Institutes should be aware of the barriers of using CPOE in addition to 
considering its benefits. While there are many benefits to CPOE, it is a major 
culture change in a hospital. Implementation without a strong physician desire 
to make it work will result in failure. People also need to be aware that any 
new technology, while it may eliminate errors, will result in the introduction 
of new types of error (Marvin, 2005 and Gray and Felky, 2004). Some of the 
barriers include the following: 
Cost: An effective CPOE system requires a substantial capital investment.  
The implementation costs of CPOE include hardware, software, technical 
support, and integration with existing systems.  
System updates: It is important that CPOE systems are updated regularly with 
information about new drugs and warnings.  
Allowing overrides: Most of the computer systems allow users to override 
warnings. This can compromise safety if a legitimate warning is overridden.  
Cultural change: CPOE systems require physicians to eliminate handwritten 
orders and instead enter orders into a computer. Depending on the 
organization, this can involve a cultural shift that many physicians will resist 
such change. Organizations need to involve physicians in the design and 
implementation of CPOE systems to ensure their support.  
Possible introduction of errors: Without a written order to compare to, a 
prescriber might select the wrong medication dose, route, or patient.  
1.2.4.6.3 Automated medication dispensing devices 
Automated drug distribution devices means automated equipment used 
for remote storage and distribution of medication for use in patient care. The 
system is supported by an electronic data base (Marvin, 2005).  
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Automated dispensing devices appeared after the advent of the unit 
dose distribution system. Their advantages include reduced rates of 
medication errors, increased efficiency of pharmacy and nursing personnel, 
allowing for more direct patient-care involvement by pharmacists and nurses, 
availability of medications where they are routinely used i.e. nursing units and 
elimination of the medications delivery delay.  
Pharmacy responsibilities 
Each facility using drug distribution devices must designate a 
pharmacist responsible for the oversight of the use of these devices. The 
responsibilities of this pharmacist are to ensure that policies and procedures 
are in place for the safe use of patient medications that are removed from the 
devices, prior to pharmacist review of the prescriber's order. Conduct of audits 
of compliance and adherence to the policies and procedures, approval of the 
medication inventory to be stocked in the automated drug distribution devices. 
The checking and stocking of medications in the automated drug distribution 
devices is reserved to a pharmacist or a pharmacy technician, ensure the 
security of medications in automated drug distribution devices by limiting 
access to authorized health care providers only and using safeguards to 
prevent unauthorized access to the devices, including termination of access at 
the end of employment. Monitoring controlled substance usage and taking 
appropriate actions and working in cooperation with nursing administration to 
maintain an ongoing medication discrepancy resolution and monitoring 
process.  
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Quality assurance and performance improvement requirements for the 
use of automated drug distribution devices   
Each hospital is required to establish and maintain a quality assurance 
and performance program that includes, but is not limited to, accuracy of 
medication filling and removal, regular review of controlled substances 
discrepancies, use of the data collected to take action to insure quality of care 
and make improvements to the automated drug distribution device system and 
documentation of the outcomes of the quality assurance activities (Marvin, 
2005). 
1.2.4.6.4 Bar coding 
Bar coding is widely used in industries to improve the accuracy. Use in 
medicine was launched lately, due to difficulties in assigning unique bar codes 
to different brands of medications. Advantages of bar coding are rapid 
identification of drug name, drug dose, administration time, rapid 
identification of staff and patients, rapid dispensing and improved accuracy 
and decreased medication administration errors (Chester and Zilz, 1989; Myer 
et al., 1991; Bates, 2000; Marvin, 2005; and Poon EG et al., 2006). 
1.2.5 Optimizing medication therapy (clinical services) 
1.2.5.1 Pharmaceutical care  
 The goal of the pharmaceutical care is to improve the patient quality of 
life through achievement of definite medication-related outcomes. The 
outcomes are cure of patient’s disease, elimination or reduction of patient’s 
symptoms, arresting or slowing of a disease process and prevention of a 
disease or symptoms. This, in turn involves three major functions: 
 
58 
 
1. Identifying potential and actual medication-related problems 
2. Resolving actual medication-related problems 
3. Preventing potential  medication-related problems 
The following are the categories of medication related problems: 
Untreated indications: The patient has a medical problem that requires 
medication therapy but not receiving a medication for the indication. 
Improper drug selection: The patient has a medication indication but taking 
wrong medication for that indication. 
Sub-therapeutic dosage: The patient has a medical problem that treated with 
too little of the correct medication. 
Failure to receive medication: The patient has a medical problem resulting 
from not receiving a medication. 
Over-dosage: The patient has a medical problem resulting from receiving too 
much of correct medication (toxicity). 
Adverse drug reactions: The patient has a medical problem resulted from an 
adverse drug reaction or drug effect. 
Drug interactions: The patient has a medical problem resulted from drug-
drug, drug-food or drug-laboratory test interaction. 
Medication use without indication: the patient is taking a medication for no 
medically valid indication. (Hepler and Strand, 1990; ASHP, 1993; Manitoba, 
2004 and ASHP, 2004).  
1.2.5.2 Pharmaceutical care planning  
Pharmaceutical care planning is a systematic, comprehensive process 
with three primary functions: (Rich, 1994; Gold and Fedder, 1992 and ASHP, 
2004). 
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1. Identify a patient's actual and potential drug-related problems. 
2. Resolve the patient's actual drug-related problems. 
3. Prevent the patient's potential drug-related problems. 
Five steps are required for creation of a pharmaceutical care plan.  
a) Create patient database  
The first step in the care planning process is the creation of a 
comprehensive patient database, which includes at minimum, the following 
information: Patient demographics, diagnoses and past medical history, 
present medications and medication history, medication allergies/intolerances, 
smoking/alcohol/caffeine/drug use history, abnormal laboratory and physical 
exam results and renal and hepatic function.  
b) Assess drug-related problems  
Following the creation of a comprehensive patient database, the 
pharmacist should evaluate the patient's drug therapy. (Strand et al, 1991 and 
ASHP, 2004). He/She should assess the patient for drug-related problems; 
determine whether drug-related problems are being treated, whether current 
drug therapy is appropriate, whether additional drug therapy is needed and if 
any of the drug-related problems may have been caused by medication.  
An understanding of the types of drug-related problems that may occur 
facilitates the evaluation process. Most drug-related problems are the result of 
not receiving an indicated drug, receiving the wrong drug , too little of the 
drug, too much of the drug, experiencing an adverse drug reaction or a drug 
interaction, not receiving the prescribed drug and receiving a drug for which 
there is no valid medical indication  
c) Establish therapeutic goals  
Therapeutic goals must be established for each drug-related problem so 
that the pharmaceutical care planning process can be effective. Therapeutic 
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goals should be definite, realistic and, if possible, measurable. Most 
therapeutic goals are made to maintain normal physiology (i.e., normalize 
blood pressure), slow progression of disease (i.e., slow progression of cancer), 
alleviate symptoms (i.e., optimize pain control), prevent adverse effects, 
control medication costs and educate the patient about his or her medication 
(Strand et al, 1991). 
d) Specify monitoring parameters  
Finally, monitoring parameters must be specified so that the patient's 
progress can be followed. Monitoring parameters must also include potential 
adverse effects; determine desired end points for each parameter and the 
frequency of monitoring (Angaran, 1991 and ASHP, 2004).   
e) Document patient's progress  
The pharmacist evaluates and documents the patient's progress in 
achieving the desired therapeutic goals and avoidance of potential adverse 
effects. The pharmaceutical care plan is updated with each major change in 
patient status (Canady and Yarborough, 1994; JCIA, 2007 and ASHP, 2004).   
The general steps involved in creating a pharmaceutical care plan are 
shown in figure 1.6.  
 
Figure 1.6. The general steps involved in creating pharmaceutical care 
plan 
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1.2.5.3 Direct patient care 
Pharmacists and clinical pharmacists provide direct patient care 
throughout the institution and they are active, integral members of medical 
service teams and assist the team by providing services including drug 
selection, pharmacokinetic assessment and drug dosing, drug information, 
patient medication counseling and education and other patient-focused 
services to optimize drug therapy outcomes (Nesbit et al, 2001; Manitoba, 
2004; SHPA, 2005 and ASHP, 2004). 
Pharmacists in ambulatory care clinics 
Working in collaborative, multidisciplinary clinics, pharmacists have 
the opportunity to optimize drug therapy and patient outcomes by educating 
patients, optimizing medication use, and monitoring medication endpoints 
(Hanes and Beata, 2005). 
Examples:  
• Dedicated pharmacist who manages the pharmacotherapy needs of 
HIV infected patients  
• Interdisciplinary cardiac risk clinic  
• Pharmacist-managed anticoagulation clinic   
• Lipid clinic co-directed by a pharmacist. 
 
Medication assessment  
Drug misadventures are defined as the largely preventable, 
unintentional negative outcomes associated with drug therapy. The literature 
illustrates relations between drug misadventure and patient morbidity, 
hospitalization and the length of hospital stay. Pharmacists in medication 
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assessment clinics or programs ensure positive patient outcomes and more 
appropriate health care utilization (Toh Cjeng et al, 2005 and Leape et al, 
1999). 
Example:  
• Pre-admission medication assessment to hospital  
• Clinical pharmacist actively participate in medical rounds    
In Canada, United States of America, Australia, Korea, Thailand and 
Malaysia pharmacists provide direct patient care using pharmaceutical care 
model. The clinical services are well established to optimize the medication 
therapy. Pharmacists are educating patients in ambulatory care clinics, 
involved in medication assessment clinics and program (LeBlanc and Dasta, 
2005).  
Based upon the above review, it is obvious that most of the services and 
activities do not exist in Sudan. Structured clinical pharmacy services are also 
not established. Therefore, the transition towards pharmaceutical care and 
patient-orientated practice has become inevitable. Accordingly, the minimum 
standards required for hospital pharmacy must be considered. 
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1.3 Aim  
The purpose of this research is to explore the current pharmaceutical 
care practices in hospitals in Khartoum state with an attempt of upgrading and 
improving hospital pharmacy services to reflect the minimum best 
recommended pharmaceutical care practices. This may help to improve 
medication use process, patient care and safety, treatment outcomes and 
ultimately patients' quality of life. 
 
1.4 Objectives 
 
1. To survey the current situation of pharmacy practice in selected 
hospitals in Khartoum State based on the minimum pharmaceutical care 
best practices standards.  
2. To determine and compare the percentage of compliance with the 
processes, activities, services and practices within these standards 
between different hospital types in Khartoum State. 
3. To set up a model for the development and implementation of the new 
globally recommended hospital pharmacy services. 
4. To implement the model in a selected hospital pharmacy (Soba 
University Hospital). 
5. To provide a future perspective for the running of the proposed 
services. 
64 
 
2. METHODOLOGY 
 
2.1 Determination of global minimum standards of best practices in 
hospitals 
A comprehensive literature review for hospital pharmacy best practices 
was conducted to provide minimum acceptable standards for pharmacies in 
hospitals. Accordingly, evidence-based best practices, their advantages and 
implementation requirements and procedures were selected and recommended 
for survey in Sudanese hospital pharmacies. 
The literature reviewed consist of best practices for hospital pharmacy 
and medication safety guide by the American Society of Hospital Pharmacist, 
Hospital Standards of Practice and Guidelines on Practice in Hospital 
Pharmacy Manual indorsed by Manitoba Pharmaceutical Association - 
Canada, Joint Commission International Accreditation Standards for Hospitals 
and the Healthcare Quality Handbook. Additionally, many topics related to 
hospital pharmacy best practices, quality improvement and medication safety 
from journals and publications were reviewed e.g. Clinical Pharmacokinetics 
Journal, Hospital Pharmacy Journal, Clinical Chemistry Journal, British 
Medical Journal, Journal of Pharmacy Practice and Research, Quality and 
safety in Health Care Journal, Pharmacotherapy, Annals of Internal Medicine, 
Drug Information Journal, British Journal of Hematology. Up-to-date best 
practices topics form internet sites were also consulted. 
The literature review covered hospital pharmacy best practices in 
different countries. e.g. United States of America, Canada, Australia England, 
Korea, Thailand and Malaysia . The selection of the six minimum standards 
for best practice was made based upon experiences in these countries. 
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2.2 Best practices assessment Survey  
Recommended international guidelines and evidence-based 
pharmaceutical care best practices were investigated. Situation analysis 
regarding the current pharmaceutical care practice in eighteen selected 
hospitals in Khartoum state was performed based on minimum standard for 
pharmacies in hospitals. The analysis was achieved by the use of a survey 
questionnaire regarding best practices assessment (Appendix A). The selected 
hospitals covered different types of hospitals, teaching, governmental, private 
and others. 
2.2.1 Study design 
The study is descriptive hospital-based that aims to portray the best 
practices in hospital pharmacies. 
2.2.2 Study area 
The hospitals pharmacies covered by the study are in Khartoum State, 
Sudan. 
2.2.3 Study population 
Pharmacies in governmental, teaching and private hospitals, with 
different types of care i.e. primary, secondary and tertiary. 
2.2.4 Sample size 
Initially, 25 hospitals were selected but the responded hospitals were 18 
hospitals. For constraint regarding time limit, the sample size ended with 18 
hospitals.  
The total number of hospitals in Khartoum State is 106, 48 are 
governmental, 19 of them are teaching and 58 are private hospitals and clinics 
with inpatient facilities (MOH, 2006).  
The sample size (18) represent 18X100   = 16.98% of the study 
population.                                                  106 
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2.2.5 Sampling procedure 
Convenience opportunistic sampling is used for data collection. 
Hospital pharmacies are selected to cover the different cities in Khartoum Sate 
with concentration on governmental and teaching hospitals.  
2.2.6 Sampling tools 
Face-to-face interviews, site visits and semi-structured questionnaire. 
2.2.7 The questionnaire 
The survey was close ended designed from 6 standards that comprised a 
total of 60 statements reflecting the minimum best practices in hospital 
pharmacies (Appendix A). It was headed with demographics to figure the type 
of hospital, type of care provided by the hospital and numbers of beds. 
Contact addresses and phone numbers to facilitate communication for follow 
up and clarification were also included. The surveys were filled by head of 
pharmacies or senior pharmacists. 
2.2.7.1 Practice management standard 
Fourteen questions covered this section. They assessed and evaluated 
the practice management standard for the surveyed hospitals. They covered 
the effective leadership, practice management necessary components, 
committee’s involvements, staff situation and management, accessibility to 
pharmacists, preparedness in case of disaster events and continuous efforts to 
improve the pharmacy services and patient outcomes.   
2.2.7.2 Drug information and education standard 
Four questions are designed to assess this standard. They evaluated the 
availability of an up-to-date drug information and participation of the 
pharmacists in education of both patients and health care providers.  
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2.2.7.3 Optimizing medication use standard 
This standard was assessed using twelve questions. The clinical and 
direct patient care activities, patient counseling and computerization of 
pharmacy services were investigated 
2.2.7.4 Medication distribution and control standard 
The majority of questions (20 questions) focused on this standard. They 
covered the medication use domains, prescribing, preparation/dispensing, 
monitoring and storage. In addition to assessment of the medication 
distribution systems used and the medication safety efforts and initiatives in 
place within the surveyed hospitals  
2.2.7.5 Facilities, equipment and information resources standard 
Eight questions to investigate facilities, equipment and information 
resources were formulated. They assessed the availability of space for 
medications storage, packaging and compounding of medications, 
compounding of sterile products, and provision of drug information, patient 
counseling, storing records, files and stationeries, administrative, educational 
and training activities. In addition to equipment required for packaging and 
compounding of medications and sterile products.  
2.2.7.6 Investigational medications standard 
Investigational medications standard situation within hospital 
pharmacies was explored by two questions that focused on the distribution and 
control of investigational drugs by pharmacy and availability of policies and 
procedures for safe and proper use of these drugs. 
2.2.8 Data and statistical analysis 
The collected data was analyzed using statistical package software 
(SPSS) and a manual calculator. Data is presented as mean ± standard 
deviation (SD) and range. 
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2.3 Proposal for expansion and upgrading of Soba pharmacy services 
Based upon the present recommendations Soba Hospital pharmacy 
service were agreed to be brought up to date based on the best recommended 
and evidence based pharmacy practices. 
2.3.1 The proposed services 
A proposal for expansion and upgrading of Soba Hospital Pharmacy 
services was prepared and it includes the following 8 services. 
 
2.3.1.1 Development of comprehensive IV admixtures program 
 (including TPN) 
All parentral drug admixtures should be prepared by pharmacists under 
sterile conditions, thus reducing patient infections, free nurses from such 
preparations allowing them for more time to patient care. This program would 
need only few staff, but it would require space and equipment. 
2.3.1.2 Implementation of unit Dose distribution system 
A unit dose drug distribution system is needed for proper control of 
medications by pharmacy. This system reduces drug wastage and nursing 
time. It increases the assurance that the correct medication has been given to 
the correct patient in the correct dosage. It also allows checking on potential 
drug interactions, it leads to huge financial saving, although it needs more 
manpower. 
 
2.3.1.3 Development of a central manufacturing and compounding area 
A pre-pack room is recommended for manufacturing bulk medications 
into unit dose ready to administer packs. 
A designated area is proposed for compounding non-sterile products at 
pharmacy. 
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2.3.1.4 Drug information 
Up-to date drug information shall be available to provide patient 
specific drug information and accurate information about drugs to the 
pharmacists, medical and nursing professionals and patients as appropriate. 
This will need just a few staff members and also expenditure on reference 
books and access to international databases on medications. 
2.3.1.5 Provision of clinical services  
The provision of pharmaceutical care represents a maturation of 
pharmacy as a clinical profession and is a natural evolution of more mature 
clinical activities of pharmacists. These services include the followings:  
• Therapeutic drug monitoring 
• Patient education and counseling 
• Medication use evaluation (MUE)  
• Medication reconciliation 
• Health care staff education 
• Total parentral nutrition 
• Pharmacist run or led clinics. e.g. anticoagulant, asthma and diabetic 
clinics. 
2.3.1.6 Narcotic room 
This is essential for secure handling of narcotics and controlled drugs 
and its related paper work. 
2.3.1.7 Quality improvement/staff development program 
This is to ensure high quality of pharmacy services provided through 
implementation of a quality improvement plan and upgrading the skills of the 
pharmacy staff.  
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2.3.1.8 Pharmacy computerization 
All modern pharmacies are computerized. This applies to all areas of 
the pharmacy, inpatient, and outpatient. The computerization allows accurate, 
safe and proper control of medication. 
2.3.2 Requirements for modern services implementation 
2.3.2.1 Space 
The existing pharmacy space is 14.7m X 17m. This is not adequate to 
fit the above motioned services and expansion. To implement the proposed 
services the space must expand and refurbishment of the existing pharmacy 
building must take place. 
Addition of 8 meter to width or 7 meter to the length will provide 
adequate space to fit all the proposed services. Figure 2.1 illustrates a lay-out 
for the proposed services at Soba Hospital Pharmacy.  
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Figure 2.1.  Lay-out for the proposed services at Soba Hospital Pharmacy  
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2.3.2.2 Equipment 
Equipment needed for the expansion and upgrading of the pharmacy 
services include the equipment for unit dose and IV admixture implementation 
and the Information technology equipments required to computerize the 
pharmacy distribution system (Appendix F). 
2.3.2.3 Estimated capital budget for Soba pharmacy expansion 
Quotations for all equipment needed based on recommended 
specifications were provided (Table 2.1 & 2.2). The total cost for the Unit 
dose and IV Admixture equipment is 277050 USD while the cost for 
information technology (IT) equipment is about 26750 USD   
 
Table 2.1 Equipment for Unit dose and IV Admixture implementation  
  
 No  Item  Qty  Unit price 
in USD 
Total Cost in 
USD 
1 Pass through refrigerator 1 20,000 20,000 
2 Trolleys large for unit dose 4 2,000 8,000 
3 Laminar flow hoods 3 20,000 60,000 
4 Chair desk high back- stool type  25 150 3,750 
5 Unit dose cart sets  45 2,000 90,000 
6 Medication refrigerator  5 5,000 25,000 
7 Unit dose tablet machine 1 30,000 30,000 
8 Unit dose liquid dispensing machine 1 30,000 30,000 
9 Bookcase for filling 2 500 1,000 
10 Fax machine  3 600 1,800 
11 Controlled medication cabinet 1 2,500 2,500 
12 Modular storage bins  1,000 5 5,000 
Total cost in USD 277,050 
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Table 2.2.  Information Technology Requirements  
 
No  Item  Qty  Unit price 
in USD 
Total Cost in 
USD 
1 Personal computer  25 750 18,750 
2 Heavy laser printer   1 2,000 2,000 
3 UD label printer  4 600 2,400 
4 IV label printer 2 600 1,200 
5 A4 printer  4 600 2,4000 
Total cost in USD 26,750 
 
The total cost for unit dose and IV admixtures services equipment is 
303,800 USD. Additional expenditure for implementation of other services, 
drug information center, narcotic services, pharmacist led clinics and narcotic 
room is also recommended. 
2.3.2.4 Staffing 
Staffing is an important factor for implementation of the proposed 
services specially Unit dose and I.V admixtures. Average US hospital survey 
(1989 – 1992) showed pharmacist and technician ratio of 7 Full Time 
equivalents (FTE’s) for inpatient drug supply per 100 beds. Soba Hospital has 
approximately 500 beds; therefore, the required staff for new inpatient drug 
supply system is about 35 FTE’s. 
2.3.2.5 Missing services  
Due to constraint regarding the space available the following services are 
not currently included in the proposed layout.  
1. Pharmacy store 
2. Deputy director office 
3. Clinicals office 
4. Quality improvement office 
5. Discharge and patient education area. 
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3. RESULTS AND DISCUSSION 
 
3.1 Determination of global minimum standards of best practices in 
hospital pharmacies 
The global minimum standard of best practices in hospital stated in 
chapter one, came up as a result of a comprehensive literature review 
regarding best practices in hospital pharmacies from different societies. The 
American Society of Health-System Pharmacist (ASHP), USA, guidelines on 
practice in hospital pharmacy from Manitoba Pharmaceutical Association, 
Canada and hospital standards of practice from Joint Commission 
International for accreditation of hospitals were consulted. These guidelines 
describe the entire standards for the best practices in hospital pharmacies. 
Experiences from different countries regarding development and upgrading of 
hospital pharmacy services showed that they constantly refer to these 
guidelines. e.g. Tawam hospital, Alain, UAE, Alrahba hospital, Abu Dhabi, 
UAE and King Faisal specialist hospital and research center, Riyadh, KSA. 
In the present work, only the recommendations which represent the 
minimum acceptable level of practice that all hospitals must have in constant 
basis were abstracted from the above mentioned guidelines. Since failure to 
provide any of these practices and services may compromise the overall 
quality of pharmaceutical care provided, it is recommended that all hospital 
pharmacies must adhere to the minimum standards of best practices in hospital 
pharmacies. Moreover, they can be useful in evaluating and assessing the 
scope and quality of these services in hospitals. 
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3.2 Best practices assessment survey 
The first step toward improving and changing the pharmaceutical care 
practice in Sudan is to identify the current situation.  
The best practices assessment survey was designed based on the 
minimum standard for hospital pharmacies, since failure to provide those 
standards will compromise the pharmaceutical care services and patient 
outcomes. 
3.2.1 Demographics 
The questionnaire was distributed to 25 hospitals and only 18 hospitals 
fully responded. Problems encountered are delay in filling the questionnaire 
by some hospitals, some filled questionnaires are not complete, many 
clarifications are required to finalize the survey and some hospitals did not fill 
the distributed questionnaire, (e.g. Omdurman Teaching and Ahmed Qasim 
Pediatric Hospitals). 
The hospitals covered, according to type of care, range, from primary to 
tertiary/acute care. The survey covered teaching hospitals, governmental, 
private and other (Charity) hospitals. The distribution of the surveyed 
hospitals according to type, type of care and bed number is shown in table 3.1. 
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Table 3.1. Distribution of surveyed hospitals 
 
No.  Hospital name  Type  Type of care  Bed No. 
1 Police Hospital  Governmental  Secondary  360 
2 Alribat University Hospital Teaching  Tertiary/Acute  300 
3 Khartoum Teaching Hospital  Teaching Tertiary/Acute 500 
4 Khartoum North Teaching 
hospital 
Teaching Tertiary/Acute 420 
5 Umm Badda Hospital Teaching  Tertiary/Acute 240 
6 Friendship Hospital Governmental Secondary 150 
7 Albuluk Hospital Governmental Secondary 160 
8 Ibn Sina Hospital Governmental Tertiary/Acute 160 
9 Tigani Almahi Hospital  Governmental Tertiary/Acute 50 
10 Soba University Hospital Teaching Tertiary/Acute 450 
11 Al Saudi Hospital (Obs)  Governmental Tertiary/Acute 200 
12 Omdurman Maternity Hospital Governmental Tertiary/Acute 180 
13 Fedail Medical Center Private  Primary  15 
14 Asia Medical Center  Private  Primary  60 
15 Albaraha Hospital Private  Tertiary/Acute 150 
16 Ear, Nose & Throat Hospital  Governmental Secondary  60 
17 Makka Eye Hospital  Charity  Secondary  150 
18 Children’s  Specialized Hospital Governmental Tertiary/Acute 200 
 
The distribution of hospitals according to the type of care provided is 
presented in figure 3.1. Tertiary/acute care hospitals represent 61.1% of the 
surveyed hospitals, while secondary care and primary care represent 27.8% 
and 11.1%, respectively. 
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Figure 3.1. Distribution of hospitals according to the 
 type of care provided 
 
Figure 3.2 illustrates classification of hospitals according to type, where  
50% are governmental hospitals, 27.8% are teaching hospitals, 16.7% are 
private hospitals and 5.5% others (charity). 
 
 
 
 
 
 
 
 
 
Figure 3.2. Classification of hospitals according to type 
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The number of beds for the surveyed hospitals falls between 15 to 500. 
The graphs below represent beds distribution according to beds range, (Figure 
3.3) and hospital size (Figure 3.4).  
 
 
 
 
 
 
 
 
Figure 3.3. Hospitals distribution according to bed number 
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Figure 3.4. Hospitals distribution according to the size 
  
Small hospitals (less than 100 beds) represent 22.2% of the sample 
surveyed, medium hospitals (more than 100 & less than 200) 33.3% and large 
hospitals (more than 200 beds) 44.4%.   
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3.2.2 Best practices survey findings 
The best practices assessment survey at Khartoum State is categorized 
into six statements representing the six minimum recommended standards. 
 
3.2.2.1 Practice management 
The findings for all hospitals surveyed showed 50% ± 22 (range, 
22.2%- 100%) compliance with practice management standard while the non-
compliance were 50% ± 22 (range, 0 - 77.8%).  
Individual practice management standard findings are shown in Table 
3.2. 
Table 3.2. Practice management standard findings 
Practice management standard 
 
Compliance Non-
compliance 
 1.   Pharmacy written mission statement  44.4% 55.6% 
2.   Pharmacy continuing education program   33.3% 66.7% 
3.   Orientation program for the new arrivals  33.3% 66.7% 
4.   Procedures for the evaluation of the staff performance  22.2% 77.8% 
5.   Job descriptions for all categories of the pharmacy staff    55.6% 44.4% 
6.   Policies and procedures covering administrative   
functions.  
33.3% 66.7% 
7.  A process to routinely monitor pharmacy workload   66.7% 33.3% 
8.  Committees participation   50% 50% 
9.  Sufficient staff to perform required functions and 
responsibilities 
44.4% 55.6% 
10. 24 -hours pharmacy coverage. 94.4% 5.6% 
11.  When 24- hour coverage is absent, on call pharmacist   
is available.  
100% 0% 
12. A disaster plan. 38.9% 61.1% 
13.  The pharmacy is responsible for product specifications, 
procurement, distribution, and control of all drugs  
83.3% 16.7% 
14. A quality improvement plan for the pharmacy.   44.4% 55.6% 
Mean ± SD 50% ± 22 50% ±  22 
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About seventy eight percent (77.8%) of hospital pharmacies surveyed 
have no procedures for evaluation of their staff performance while 66.7 % of 
hospital pharmacies do not have a continuing education program, orientation 
program for new arrivals or policies and procedures for covering 
administrative functions.  
Almost two thirds (66.1%) of hospital pharmacies do not have a 
disaster plan while 55.6% of hospital pharmacies do not have a written 
mission for the department, quality improvement plan and sufficient staff to 
perform the required pharmacy functions and responsibilities. 
In one half of hospital pharmacies, their pharmacists do not participate 
in the committees responsible for provision of the pharmaceutical care while 
44.4% of hospital pharmacies do not have written job descriptions.  
One third of hospital pharmacies do not have a process for monitoring 
the pharmacy workload while 16.77% are not responsible for product 
specifications, procurement, distribution and control of all drugs within the 
hospital.   
All hospitals complied with the 24 hour accessibility of pharmacist and 
94.4% have a 24- hour’s pharmacy coverage. In only one hospital (5.6%), on 
call pharmacist is available and this hospital does not have critical care 
services, this makes the compliance 100% 
From the above findings it is obvious that the standard of practice 
management was compromised, which affects the delivery of pharmaceutical 
care services in general. Effective leadership and practice management are 
necessary for the delivery of pharmaceutical care services in a manner 
consistent with hospital’s and patient’s needs in addition to continuous 
improvement of in patient care outcomes (Zilz et al., 2004). Staffing is not 
adequate to perform the existing functions and activities which are already 
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underprovided and not up to the minimum standard of pharmaceutical care 
best practice. Pharmacist shortage has a negative impact on providing the 
pharmaceutical care services and support personnel are needed to facilitate 
pharmaceutical care implementation. 
 
3.2.2.2 Drug information and education  
The overall compliance with drug information and education standard 
was 38.9% ± 21 (range, 11.1% - 61.1%). while the non-compliance was 
61.1% ± 21 (range, 38.9% - 88.9%).  
Table 3.3. illustrates the findings for drug information and education 
standard. About eighty nine percent (88.9%) of hospital pharmacies do not 
have medication therapy monographs for medications under consideration for 
pharmacy formulary addition or deletion while 61.1% of hospital pharmacies 
do not provide hospital staff with information about the use of medications on 
an ongoing basis. Up-to-date drug information is not available in 55.6% of 
hospitals and in 38.9% pharmacists do not participate actively in patient 
education. 
 
Table 3.3. Drug information and education findings 
 
Drug information and education Standard 
 
Compliance  Non-
compliance 
1.   Up-to-date drug information. 44.4% 55.6% 
2. Medication-therapy monographs  11.1% 88.9% 
3. Pharmacists actively participate in patient education. 61.1% 38.9% 
4. Pharmacists keep the hospital staff informed about the 
use of medication on an on-going basis  
38.9% 61.1% 
Mean ± SD 38.9%  ± 21 61.1%  ± 21 
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From the above findings, the pharmacists are not able to play their role 
of drug information provision to health care providers; however provision of 
drug information for patients was better but still compromised. Provision of 
drug information is a fundamental professional responsibly of pharmacist in 
hospitals. The goal of providing evidence supported information should be to 
enhance the quality of patient care and improve patient outcomes (Troutman, 
1994 and Manitoba, 2004) and not adhering to this will decrease the quality of 
care and reduce patient outcomes which are the focus in pharmaceutical care.  
3.2.2.3 Optimizing medication use 
The overall compliance with optimizing medication therapy standard 
was 18.1% ± 24 (range, 0 – 83.3%) while the non-compliance was 81.9 % ± 
24 (range, 16.7% – 100%). The findings are illustrated in table 3.4. 
 
Table 3.4. Optimizing medication use findings 
Optimizing medication therapy standard 
 
Compliance  Non-
compliance 
1. Policies and procedures covering clinical functions   exist. 11.1% 88.9% 
2. Clinical actions and recommendations by pharmacist were 
documented in patient medical record. 
5.6% 94.4% 
3. Pharmacists have an access to medication histories 11.1% 88.9% 
4.  All medications orders are verified and reviewed for 
appropriateness by a pharmacist before dispensing. 
83.3% 16.7% 
5. Medication orders clarification and intervention 27.8% 72.2% 
6.  A medication use evaluation (MUE) program exists 16.7% 83.3% 
7. Documentation of pharmaceutical care and patient outcomes. 0% 100% 
8. Pharmacists are involved in the development of clinical care 
plans 
38.9% 61.1% 
9. A total parentral nutrition program exists. 0% 100% 
10. An on-going therapeutic drug monitoring process is    available 0% 100% 
11. Patient education and counseling program exists. 22.2% 77.8% 
12. There is a computerized pharmacy system in place. 0% 100% 
Mean ± SD 18.1% ± 24 81.9% ± 24 
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All hospitals do not have a total parentral nutrition program, an on-
going therapeutic drug monitoring (TDM) process, or a process for consistent 
documentation of pharmaceutical care plans and patient outcomes. These 
reflect the absence of structured clinical activities and pharmaceutical care 
planning. 
All hospitals also do not have computerized pharmacy systems which 
support the dispensing, labeling, clinical activities, maintain pharmacy patient 
profile and manage medication use and support all pharmaceutical care 
practices. This will keep pharmacists in their old traditional role, product- 
focus dispensing, thus they will not be capable to practice pharmaceutical 
care. 
Almost all hospitals (94.4%) are not documenting the clinical actions 
and recommendations in patient medical record while 88.9% of hospital 
pharmacies do not have policies and procedures covering the clinical functions 
and the pharmacists do not have an access to medication histories. With 
pharmaceutical care, pharmacist requires to have access to patient histories for 
purpose of medications assessment and reconciliation. Whittington and Cohen 
(2004) in a study regarding healthcare’s journey in patient safety, a series of 
interventions including medication reconciliation introduced over a period of 
7 months was shown to successfully decrease medication errors by 70% and 
reduce adverse drug events by over 15%. 
About eighty three percent (83.3%) of hospital pharmacies do not have 
a medication use evaluation program. This reflects that lack of assuring 
medications is used appropriately, safely and effectively while 77.8% of 
hospital pharmacies do not have a patient education and counseling program. 
This reflects the deficiency of direct patient care. 
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Documentation of medication orders clarifications and interventions 
were 72.2% while 61.1% of hospital pharmacies are not involved in the 
development of clinical care plans. 
In a small percentage of hospitals (16.7%), hospital pharmacies do not 
verify or review the medications order for appropriateness by a pharmacist 
before dispensing. As a core requirement all orders must be verified before 
dispensing. 
Pharmacists have the opportunity to optimize drug therapy and patient 
outcomes by educating patients, optimizing medication use, and monitoring 
medication endpoints (ASHP, 1988 and Hanes and Beata, 2005). It is clear 
from the above analysis that optimizing of medication therapy which reflects 
the pharmaceutical care vision, direct patient care and clinical services is 
severely lacking. These processes, functions, activities, programs and services 
need to be brought up to the minimum required standard. Pharmaceutical care 
vision must be considered, structured clinical services have to be developed 
and processes have to be re-engineered. Doing so will improve patient 
outcomes and also it is a challenging opportunity for pharmacists to promote 
the pharmacy profession.  
 
3.2.2.4 Medication distribution and control  
The overall compliance with drug distribution and control was 37.8% ± 
32 (range, 0 – 88.9%) while the non-compliance was 62.2% ± 32 (range, 
11.1% – 100%). The findings for this standard are illustrated in table 3.5. 
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Table 3.5. Medication distribution and control findings 
 
Medication distribution and control standard 
 
Compliance  Non-compliance  
1.   Policies and procedures covering operational functions exist. 38.9% 61.1% 
2.   A formulary is maintained by the pharmacy. 61.1% 38.9% 
  3.   Medications are prescribed by individuals who have 
prescribing privileges  
44.4% 55.6% 
4.   Drug formulations which are not available commercially 
shall be prepared by pharmacy against evidence based 
references. 
38.9% 61.1% 
5.   Pharmacy keeps and maintains patient’s medications 
profiles.  
16.7% 83.3% 
6.   IV admixture program exists. 0% 100% 
7.   Quality assurance procedures for the preparation of sterile 
products exist. 
0% 100% 
8.   Unit dose is the drug distribution system  0% 100% 
9.   Medications are stored under proper conditions of sanitation, 
ventilation, temperatures, light, moisture, 
88.9% 11.1% 
10. Medications are stored under proper conditions of security.  88.9% 11.1% 
11. An on-going program for monitoring, reporting and 
preventing a adverse drug reactions exists. 
0% 100% 
12.  An on-going program for monitoring reporting and 
preventing of medication errors exists. 
27.8% 72.2% 
13.  A list of (do not use abbreviations and dose designations) 
should exist.  
22.2% 77.8% 
14. A high alert medication management plan exists  0% 100% 
15. An established process and written policy for drug product 
recalls exists. 
22.2% 77.8% 
16. Guidelines for the use of the patient’s “own medication” 
while at the hospital exists. 
27.8% 72.2% 
 17. Guidelines for the use of drug samples exist. 33.3% 66.7% 
18. Accountability procedures for the controlled drugs exist. 77.8% 22.2% 
19. All medication storage areas are inspected routinely. 88.9% 11.1% 
20. Floor stocks are limited to emergency medications and 
safely used items.  
77.8% 22.2% 
Mean ± SD 37.8% ± 32 62.2% ± 32 
 
All hospital pharmacies do not have an IV admixture program and the 
quality assurance procedures for the preparation of sterile products are absent. 
This compromised the pharmaceutical care due to lack of quality and control 
for the prepared sterile products. Preparation of all parenteral drugs admixture 
under sterile conditions reduces patient infections which in turn can decrease 
patient hospitalization and morbidity (USP-797, 2005 and Kastango, 2005). 
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All hospital pharmacies do not have a unit dose drug distribution 
system. Unit dose is the recommended safe and cost effective method for drug 
distribution and control (Murrary and Shojania, 2001). It reduces the incident 
of medication errors. A cross-sectional comparison of 2 hospitals in Germany 
and one hospital in the UK (Taxis et al., 1998), showed reduced rates for 
medication errors with unit dose system. The UK hospital using traditional 
ward stock system showed medication error of 8.0% (6.2 - 9.8%), German 
hospital using traditional ward stock system, 5.1% (4.4 - 5.8%) and German 
hospital using unit-dose system, 2.4% (2.0 - 2.8%). In addition, unit dose 
system is core element for Joint Commission International Accreditation for 
hospitals (JCIA, 2007). In absence of unit dose and IV admixture systems 
pharmaceutical care practice is definitely lagging behind. 
All hospital pharmacies do not have an adverse drug reaction 
monitoring, reporting and prevention program. This reflects absence of the 
safety assessment for drugs therapies, especially new ones and lack of quality 
improvement initiatives in medication use. 
All hospital pharmacies do not have a high alert medication 
management plan. High alert medication management plan is a JCIA patient 
safety goal. Missing such requirement will increase the risk of patient harm 
with use of those medications (JCIA, 2007).  
About Eighty three percent (83.3%) of hospital pharmacies do not keep 
and maintain a patient medication profile while 77.8% of hospital pharmacies 
did not have neither a list of “do not use dangerous abbreviation” nor a 
process and written policy for drug recalls. Availability of a “do not use 
dangerous list” eliminates the hazards of use of these prohibited abbreviations 
which is associated with medications errors encountering (JCIA, 2007; Lesar, 
2005 and Saborn, 2005).  
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In 72.2% of hospital pharmacies, there were no program for 
monitoring, reporting and preventing of medication errors and no guidelines 
available for the use of patient medications brought from home. This reflects 
lack of pharmacy control on the medication use and it is a source of 
medication error possibility (JCIA, 2007). Medication errors should be 
reported, analyzed and the outcomes used for education to prevent future 
occurrence. It is a long term quality improvement and medication safety 
approach (Gragg, 2005 and Cousins, 2005). 
Two thirds of hospital pharmacies do not have guidelines for the use of 
drug samples. Pharmacy must control the use the samples to ensure proper 
storage, maintenance of records and product integrity (JCIA, 2007). 61.1% of 
hospital pharmacies do not have policies and procedures covering the 
operational functions and do not prepare extemporaneous drug formulations 
against evidence-based references.  
In 55.6% of hospitals, the medications are not prescribed by the ones 
having the prescribing privileges while 38.9% of hospital pharmacies do not 
maintain a formulary and 22.2% do not limit the floor/ward stocks to 
emergency medications and safely used drugs. 
Only 11.1% of hospital pharmacies do not store their medications under 
proper conditions of sanitation, ventilation, temperatures, light, moisture, 
security and do not inspect the medication storage areas routinely. This 
reflects that most hospitals are practicing proper, safe and secure storage of 
medications. The adherence to these elements of this standard is quite 
satisfactory. Hopefully, this higher rate of compliance can be extended to the 
other practices. The prime responsibility of pharmacy is to control and 
distribute medications within the hospital (ASHP, 1996 and Manitoba, 2004). 
From the analysis, this standard is underprovided and lacks many core 
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elements, services and processes e.g. unit dose system and IV admixture 
program. Redesigning of pharmacy systems is required to bring this standard 
up to the minimum that is required.  
 
3.2.2.5 Facilities, equipment and information resources  
 
The overall compliance with facilities, equipment and information 
resources standard was 44.5% ± 29 (range, 0 – 100%) while the non-
compliance was 55.5% ± 29 (range, 0 – 100%). The results are illustrated in 
table 3.6. 
Table 3.6. Facilities, equipments and information resources findings 
 
Facilities, equipment and information resources standard 
 
Compliance  Non-
compliance 
1.   Facilities for medication storage are available.  100% 0% 
2.   Designated space and equipment for packaging and   
      compounding of medications exists. 
33.3% 66.7% 
3.  Designated space and equipment for compounding of 
sterile products exists. 
0% 100% 
4.   Adequate space, resources are available to facilitate 
provision     of drug information. 
44.4% 55.6% 
5.   A private area for patient counseling and education 
exists. 
27.8% 72.2% 
6.   Offices for administrative activities are available. 38.9% 61.1% 
7.   Adequate space for storing records, files and stationeries 
exists  
55.6% 44.4% 
8.   Meeting area for administrative, educational and training 
activities. 
55.6% 44.4% 
Mean ± SD 44.45% ± 29 55.55% ± 29 
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All hospital pharmacies surveyed have facilities for medication storage 
but do not have designated space and equipment for compounding of sterile 
products. 
About seventy two percent (72.2%) of hospital pharmacies surveyed do 
not have a private area for patient counseling and education. A private area is 
required in outpatient dispensing areas to ensure patient privacy and 
confidentiality, since education and counseling recommended is more 
effective when conducted in a comfortable, confidential and safe place 
(ASHP, 1997 and Manitoba, 2004). 
Two thirds of hospital pharmacies do not have space for packaging and 
compounding of drugs. A designated space is one of the minimum 
requirements for packaging and compounding of medications to promote 
efficiency and minimize potential for contamination of the products while 
61.1% of hospital pharmacies do not have offices for administrative activities. 
In 55.6% of hospital pharmacies there were no adequate space, resources to 
facilitate the provision of drug information. Space and resources for both 
administrative and professional activities are required to ensure optimal 
performance, smooth, efficient work flow and quality patient care. (Troutman, 
1997 and Manitoba, 2004). In 44.4% of hospital pharmacies there were no 
adequate space for storing records, files and stationeries and the same 
percentages do not have meeting area for administrative, educational and 
training activities.  
Facilities are essential for implementation of best practices and 
provision of pharmacy administrative, operational and clinical functions; 
equipments are required for packaging and compounding of medications, IV 
admixture program and other pharmacy functions. Information resources are 
essential for provision of drug information. The analysis showed that the space 
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is not adequate for the existing services. Space is a success factor for best 
practices implementation and should be considered when designing the 
modern pharmacy services. Equipment is the second success factor for best 
practices implementation. All equipment needed for pharmaceutical care best 
practices implementation must be availed. Resources and space are required 
for provision of drug information especially electronic resources. 
 
3.2.2.6 Investigational medications 
About seventy eight percent (77.8%) of hospital pharmacies do not 
have policies and procedures for safe and proper use of investigational 
medications while 66.7% do not distribute and control all investigational 
drugs. 
The overall compliance with this standard was 27.8% ± 8 (range, 
22.2% – 33.3%) while the non-compliance was 72.2% ± 8 (range, 66.7% – 
77.8%). The findings are illustrated in table 3.7. 
Drug distribution and control is the prime responsibility of pharmacy 
including the investigational drugs. This standard is underprovided. Policies 
and procedures for safe and proper use of investigational drugs should be 
developed and followed, in addition to dispensing and controlling of all 
investigational drugs by the pharmacy. 
 
Table 3.7. Investigational medications findings 
 
Investigational medications standard Compliance Non-compliance 
  1.  Policies and procedures for safe and proper use of 
investigational medications are developed and  
followed 
22.2% 77.8% 
2. Pharmacy distributes and controls all 
investigational drugs 
33.3% 66.7% 
Mean ± SD 27.8 ± 8 72.2 ± 8 
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3.2.3 Overall Pharmaceutical care best practices assessment 
The overall compliance of best practices was 36.2% ± 11 (range, 18.1% 
– 50%) while the non-compliance was 63.8% ± 11 (range, 50% - 81.9%). 
This reflects that the pharmaceutical care best practices in Khartoum State are 
severely underprovided and far away from the acceptable minimum level of 
practice required in hospital pharmacies.  
The overall compliance of best practices at teaching, governmental, 
private and other hospitals (charity) hospitals was 36.2%, 36.5%, 31.1% and 
48.7%, respectively.  
Figure 3.5 compare the overall compliance and non-compliance of best 
practices in all hospitals and in different hospitals type.  
 
 
  
 
` 
 
 
 
 
 
 
Figure 3.5. Best practice compliance/non-compliance in all  
hospitals and in different hospitals type 
 
The adherence to the pharmaceutical care best practices is better in 
others hospitals (charity) than governmental, teaching and private hospitals, 
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respectively. The hospital adhered more to acceptable minimum standards for 
pharmaceutical care best practices is a charity hospital (Mekka Hospital). This 
may be due to the availability of financial support with funds from abroad. 
The least to adherence are the private hospitals, while the governmental 
hospitals are slightly better than the teaching hospitals and all hospitals 
average adherence; however the adherence to the acceptable minimum 
standards for pharmaceutical care best practices in all hospitals surveyed is 
considerably bellow the minimum standards. Private hospitals are expected to 
be better in adherence to best practices since they have the financial support 
and serve fewer patients than governmental and teaching hospitals. However, 
this may be due to lack of exposure to pharmacy practices training.  
Figure 3.6. compare practice management standard in different 
hospitals type. The adherence is better in governmental hospitals than others 
(charity), teaching and private respectively. 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6. Practice management compliance/non- compliance   
according  to hospitals type. 
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The adherence to drug information and education standard practices is 
better in others (charity) hospitals than teaching, private and governmental 
respectively, as shown in figure 3.7. 
 
 
 
 
 
 
 
 
Figure 3.7. Drug information and education compliance/non-compliance 
according to hospitals type. 
 
Figure 3.8 shows the adherence to optimizing medication therapy 
standard is slightly better in governmental hospitals than private, teaching and 
others (charity) respectively. 
 
 
 
 
 
 
 
 
Figure 3.8. Optimizing medication therapy compliance/non-compliance 
according to hospitals type 
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The adherence to medication distribution and control standard is a little 
bit better in governmental hospitals than private, teaching and others (charity) 
respectively as shown in figure 3.9. 
 
 
 
 
 
 
 
 
 
Figure 3.9.  Medication distribution and control compliance/non- 
compliance according to hospitals type 
 
The adherence of facilities, an equipment and information resources 
standard practice is better in others (charity) hospitals than teaching, 
governmental and private respectively as shown in figure 3.10. 
 
 
 
 
 
 
 
 
 
Figure 3.10. Facilities, equipment and information resources 
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The adherence of Investigational medication standard practice is better 
in others (charity) hospital than private, teaching and governmental 
respectively as shown in figure 3.11.   
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11. Investigational medications compliance/Non-compliance 
according to hospitals type 
 
 
3.3 The Soba project 
The results of the best practices survey for Soba Hospital as a potential 
hospital for implementation of modern pharmaceutical services revealed the 
followings: The survey findings are presented in Table 3.8.  
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Table 3.8.  Soba Hospital best practices survey results. 
Practice management 
 
Yes  No 
1. The pharmacy has a written mission statement that is consistent with the 
mission of the hospital. 
 X 
2. A continuing education program for the pharmacy staff exists. 
 
 X 
3. An established orientation program for the new arrivals to the hospital, 
pharmacy and respective positions exists.  
 X 
4. Procedures for the evaluation of the staff performance exists 
 
 X 
5. Written job descriptions for all categories of the pharmacy staff exists. 
 
 X 
6. Policies and procedures covering administrative functions exist.  
 
 X 
7. A process exists to routinely monitor pharmacy workload 
  
 X 
8. Pharmacist participate in the committees responsible for provision of patient 
care  
 
 X 
9. The pharmacy has sufficient staff to perform required functions and 
responsibilities 
 
 X 
10. 24 -hours pharmacy coverage exist. 
 
 X 
11. When 24- hour coverage is absent, on call pharmacist is available.  
 
√  
12. A disaster plan exists for providing pharmaceutical care in case of disaster 
event. 
√  
13. The pharmacy is responsible for product specifications, procurement, 
distribution, and control of all drugs used within the hospital.  
√  
14. A quality improvement plan for the pharmacy exists.   
 
 X 
Drug information and education 
 
Yes No 
15. Up-to-date drug information exists. 
 
 
X 
16. Medication-therapy monographs for the medications under consideration 
for the formulary addition or deletion are available. 
 X 
17. Pharmacists actively participate in patient education. 
 
 X 
18. Pharmacists keep the hospital staff informed about the use of medication on 
an on-going basis through appropriate publications, presentations & 
programs. 
 X 
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Optimizing medication therapy  
 
Yes No 
19. Policies and procedures covering clinical functions exist. 
 
 X 
20. Clinical actions and recommendations by pharmacist were documented in 
patient medical record. 
 X 
21. Pharmacists have an access to medication histories √  
22. All medications orders are verified and reviewed for appropriateness by a 
pharmacist before dispensing. 
√  
23. Medication orders clarification and intervention should be documented 
either at the patient medical record or the pharmacy copy of the medication 
order 
 
 X 
24. A medication use evaluation (MUE) program exists to ensure that 
medications are used appropriately, safely and effectively. 
 X 
25. An ongoing process for consistent documentation of pharmaceutical care 
and patient outcomes exists. 
 X 
26. Pharmacists are involved in the development of clinical care plans 
involving medication therapy. 
 X 
27. A total parentral nutrition program exists. 
 
 X 
28. An on-going therapeutic drug monitoring process is available 
 
 X 
29. Patient education and counseling program exists. 
 
 X 
30. There is a computerized pharmacy system in place. 
 
 X 
Medication distribution and control 
 
Yes  No  
31. Policies and procedures covering operational functions exist. 
 
 X 
32. A formulary of approved medications for use at the hospital is maintained 
by the pharmacy. 
 
 X 
33. Medications are prescribed by individuals who have prescribing privileges  X 
34. Drug formulations which are not available commercially shall be prepared 
by pharmacy against evidence based references. 
√  
35. Pharmacy keeps and maintains patient’s medications profiles. 
 
 X 
36. All sterile products were prepared and labeled in a clean room  
      under aseptic technique by appropriately trained personnel. 
 X 
37. Quality assurance procedures for the preparation of sterile products exist. 
 
 X 
38. Unit dose is the drug distribution system  X 
39. Medications are stored under proper conditions of sanitation, ventilation, 
temperatures, light, moisture, 
 X 
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40. Medications are stored under proper conditions of security. 
 
√  
41. An on-going program for monitoring, reporting and preventing adverse 
drug reactions exists. 
 X 
42. An on-going program for monitoring reporting and preventing of 
medication errors exists. 
 X 
43. A list of (do not use abbreviations and dose designations) should exist. 
Medications orders and prescriptions containing such abbreviations are not 
accepted by pharmacy.  
 X 
44. A high alert medication management plan exists  
 
 X 
45. An established process and written policy for drug product recalls exists. 
 
 X 
46. Guidelines for the use of the patient’s “own medication” while at the 
hospital exists. 
 X 
47. Guidelines for the use of drug samples exist. 
 
 X 
48. Accountability procedures for the controlled drugs exist. 
 
√  
49. All medication storage areas are inspected routinely to ensure absence of 
expired items. 
√  
50. Floor stocks are limited to emergency medications and safely used items 
(e.g., mouthwashes, disinfectants and antiseptic solutions). 
 X 
Facilities, equipment and information resources   
 
Yes No 
51. Facilities for medication storage are available.  
 
√  
52. Designated space and equipment for packaging and compounding of 
medications exists. 
√  
53. Designated space and equipment for compounding of sterile products exists. 
 
 X 
54. Adequate space, resources are available to facilitate provision of drug 
information. 
 X 
55. A private area for patient counseling and education exists.  X 
56. Offices for administrative activities are available.  X 
57. Adequate space for storing records, files and stationeries exists 
 
 X 
58. Meeting area for administrative, educational and training activities is 
available. 
 
 X 
Investigational medications  Yes  No  
59. Policies and procedures for safe and proper use of investigational 
medications are developed and followed 
 
X 
60. Pharmacy distributes and controls all investigational drugs 
 
 
X 
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3.3.1 Practice management  
The compliance with practice management standard was 15.4% while 
the non-compliance was 84.6% as shown in figure 3.12.  
 Almost all elements for the practice management were deficient, the 
only existing are 2 elements  
 
 
 
 
 
   
 
 
 
Figure 3.12. Soba practice management findings 
 
Soba hospital pharmacy does not have a written mission statement, a 
continuing education program for pharmacy staff and no orientation program 
for new arrivals established. Procedures for the evaluation of staff 
performance do not exist and no written job description for the staff. A written 
mission is required to reflect both patient care and administrative 
responsibilities. For a teaching and research hospital, educational and research 
responsibilities are required to be stated in the pharmacy mission (ASHP, 
1997; Manitoba, 2004 and JCIA, 2007). 
Pharmacy does not have policies and procedures covering 
administrative functions. They are required to serve as a reference for 
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pharmacy staff regarding administrative functions (Manitoba, 2004 and 
ASHP, 1995). 
No process exists to monitor the pharmacy workload. This affects 
staffing and financial planning, since their planning depends on the workload. 
Soba hospital pharmacists do not participate in committees responsible 
for provision of patient care. This reflects lack of direct patient care and 
diminished pharmaceutical care concept. 
Pharmacy does not have sufficient staff to perform required functions 
and responsibilities. Pharmacists and support staff are not adequate to perform 
the existing functions and activities which are already underprovided.  
Pharmacy staff shortage has a negative impact on providing the 
pharmaceutical care services and support personnel are needed to facilitate 
pharmaceutical implementation. 
Pharmacy does not have a quality improvement plan. This reflects the 
absence of systemic and continuous quality improvement efforts and 
initiatives to improve the pharmacy services and patient outcomes. 
The only available elements of the practice management standard are 
24- hour pharmacy coverage and responsibility of pharmacy towards product 
specifications, procurement, distribution and control of drugs used within the 
hospital. 
From the above findings, the standard of practice management was 
severely underprovided which in turn will negatively affect the delivery of 
pharmaceutical care services. Staffing (2 pharmacists, including the head of 
pharmacy and 13 assistants) is not adequate to perform the existing functions 
and activities which are already underprovided and not up to the minimum 
standard of pharmaceutical care best practice. These justify the need to hire 
more staff. 
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3.3.2 Drug information and education  
The compliance with drug information and education standard was zero 
(Figure 3.13). 
 
 
 
 
 
 
 
 
Figure 3.13. Soba drug information and education findings 
 
Soba hospital pharmacy does not have up-to-date drug information, 
medication therapy monographs for the medications under consideration for 
formulary addition or deletion. Their pharmacists does not participate in 
patient education and does not keep the hospital staff informed about the use 
of medications on an on-going basis through appropriate publications, 
presentations and programs. 
These findings reflects that the drug information and education standard 
is completely lacking which jeopardize the dissemination of information 
throughout the medication and patient management process. 
 
Yes
No
102 
 
3.3.3 Optimizing medication therapy findings 
The compliance with optimizing medication therapy standard was 
16.7% while the non-compliance was 83.3%. Only 2 out of the 12 minimum 
elements for optimizing medication therapy standard were provided (Figure 
3.14). 
 
 
 
 
 
 
 
 
 
Figure 3.14. Soba optimizing medication therapy findings 
 
Soba hospital pharmacy does not have policies and procedures covering 
the clinical functions. These policies are required to serve as a reference for 
pharmacy staff regarding clinical functions (Manitoba, 2004 and ASHP, 
1995). 
Clinical actions and recommendations by pharmacists were not 
documented in patient medical record and medication orders clarification and 
intervention were also not documented. With pharmaceutical care, pharmacist 
require to have access to patient histories for purpose of medications 
assessment to ensue positive patient outcomes, since literature related 
medication misadventure to patient morbidity, hospitalization and increased 
length of hospital stay (Toh Cjeng et al, 2005 and Leape et al, 1999). 
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Soba hospital pharmacy doses not have a medication use evaluation 
program. This reflects that lack of assuring medications is used appropriately, 
safely and effectively, since medication use evaluation (MUE) is a quality 
improvement system that focuses on evaluating and improving medication–
use and/or medication use processes with the goal of optimal patient 
outcomes. 
Soba hospital pharmacy does not have a process for consistent 
documentation of pharmaceutical care plans and patient outcomes and the 
pharmacists are not involved in the development of clinical care plans 
involving medication therapy. This reflects the absence of structured clinical 
activities and pharmaceutical care planning. 
Soba hospital pharmacy does not have a total parenteral nutrition 
program or an on-going therapeutic drug monitoring (TDM) process. It does 
not have a patient education and counseling program which reflects absence of 
direct patient care. 
Soba hospital pharmacy does not have computerized pharmacy systems 
which support the dispensing, labeling, clinical activities and maintains 
pharmacy patient profile. 
The only existing two practices of the optimizing medication therapy 
standard are verification and review of medications orders for appropriateness 
by a pharmacist before dispensing and pharmacists have an access to 
medication histories for each patient medical record. 
From the above findings, this standard is significantly underprovided. 
Almost all practices of this standard were missing. Pharmaceutical care and 
direct patient care are absent. No clear structured clinical services and 
activities are available. When pharmacists provide direct patient care, they do 
so by using a pharmaceutical care model. Pharmaceutical care is that 
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component of pharmacy practice which entails the direct interaction of the 
pharmacist with the patient for the purpose of caring for that patient’s drug-
related needs. Pharmaceutical care involves communication with patients, 
analysis of patient specific data and application of pharmacotherapeutic 
knowledge to recommend the most appropriate therapy for patients, and then 
monitoring of that therapy for its desired outcome. Numerous direct patient 
care and team support based activities may be performed by pharmacists, 
depending upon the needs of the patients serviced by the particular health care 
team. Pharmacists can provide patient care services including: drug therapy 
monitoring, therapeutic and pharmacokinetic consultations, medication 
assessments, and patient education (SHPA, 2005). 
3.3.4 Medication distribution and control 
Only 4 out of 20 (20%) of the services are available (Figure 3.15). 
 
 
 
 
 
 
 
 
 
 
Figure 3.15. Soba medication distribution and control findings 
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Existing practices  
The followings practices were available at Soba hospital pharmacy: 
Drug formulations which are not available commercially are prepared by 
pharmacy against evidence based references. Accountability procedures for 
the controlled drugs exist, the medications are stored under proper conditions 
of security and medication storage areas are inspected routinely. 
Non existing practices 
This standard is missing a considerable number of practices as shown in 
table 3.9. 
 
Table 3.9. Soba hospital medication distribution and control standard – 
non existing practices 
Medication distribution and control  
1.  Policies and procedures covering operational functions exist. 
  2.  A formulary is maintained by the pharmacy. 
  3.  Medications are prescribed by individuals who have prescribing privileges only. 
      4.  Pharmacy keeps and maintains patient’s medications profiles.  
  5.  IV admixture program exists. 
6.  Quality assurance procedures for the preparation of sterile products exist. 
7.  Unit dose is the drug distribution system  
8. Medications are stored under proper conditions of sanitation, ventilation,  temperatures, 
light, moisture, 
9.  An on-going program for monitoring, reporting and preventing adverse drug reactions 
exists. 
10. An on-going program for monitoring reporting and preventing of medication errors 
exists. 
11. A list of (do not use abbreviations and dose designations) should exist.  
     12. A high alert medication management plan exists  
 13. An established process and written policy for drug product recalls exists. 
14. Guidelines for the use of the patient’s “own medication” while at the hospital exists. 
15. Guidelines for the use of drug samples exist. 
16. Floor stocks are limited to emergency medications and safely used items 
 
A total of 16 elements out of 20 for the medication distribution and 
control standard are completely missing. 
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The prime responsibility of pharmacy is to control and distribute 
medications within the hospital. From the analysis, this standard is lagging 
behind and lacks many core elements, services and processes. Ideally, all 
medications used in the hospital pharmacy should be prepared and dispensed 
by unit dose form (Pedreson et al, 2006). Redesigning and re-engineering of 
pharmacy system is required to bring this standard up to the minimum 
requirement.  
 
3.3.5 Facilities, equipment and information resources 
The compliance with facilities, equipment and information resources 
standard was 25% while the non-compliance was 75%. Only 2 out of 8 
elements for facilities, equipment and information resources are available 
(Figure 3.16). 
 
 
 
 
 
 
Figure 3.16. Soba Facilities, equipment and information  
resources findings 
 
Soba hospital pharmacy has facilities for medication storage and a 
designated space for packaging and compounding of drugs but does not have 
designated space and equipment for compounding of sterile products. 
Adequate space, resources to facilitate the provision of drug information and a 
private area for patient counseling and education are not available. A private 
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area is required in outpatient dispensing areas to ensure patient privacy and 
confidentiality. 
There are no offices for administrative activities, no adequate space for 
storing rerecords, files and stationeries and no meeting area for administrative, 
educational and training activities. 
Facilities are essential for implementation of best practices and 
provision of pharmacy administrative, operational and clinical functions; 
equipments are required for compounding of sterile products. 
Information resources are essential for provision of drug information. 
The analysis indicated that the space is not enough for the existing 
services. Space is a success factor for best practices implementation and 
should be considered when re-designing the pharmacy services. Equipment 
are the second success factor for best practices implementation. All equipment 
needed for pharmaceutical care best practices implementation must be availed. 
 
3.3.6 Investigational medications   
The compliance with investigational medications standard was zero 
(Figure 3.17).  
 
 
 
 
 
 
 
 
Figure 3.17 Soba investigational medications findings 
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Soba hospital pharmacy does not have policies and procedures for safe 
and proper use of investigational medications and the pharmacy does not 
distribute and control the investigational drugs. 
As teaching hospital investigational medications is an important 
standard. Definitely investigational drugs are used within Soba hospital but 
not controlled by pharmacy. The prime responsibility of pharmacy is drug 
distribution and control including the investigational drugs. 
This standard is completely not provided. 
 
3.3. 7 Overall best practices assessment at Soba Hospital Pharmacy 
The overall compliance of the best practices was 12.9% ± 9.6 (range, 0 
- 25%) while the non-compliance was 87.1% ± 9.6 (range, 75% - 100%). This 
reflects that pharmaceutical care best practices are significantly underprovided 
and far away from the acceptable minimum level of practice required.  
Two standards out of the 6 minimum standards for hospital pharmacy 
do no exist. The practices for the rest four standards are lagging behind. 
Essential and core services within the minimum standards do not exist. 
Figure 3.12 compares the compliance with best practices standards and 
overall best practices between Soba hospital and the overall hospitals. 
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Figure 3.18.  Comparison of compliance findings: Soba hospital vs. 
average for all hospitals 
 
It is clear that adherence at Soba hospital pharmacy to different 
standards of best practices was bellow the average for all hospitals surveyed. 
The optimizing of the medication therapy standard was near to the average of 
all hospitals; however, it is significantly underprovided.   
 
From the site visit to Soba pharmacy the following findings are 
identified: 
Space is not enough to provide the pharmaceutical care best practices. The 
existing pharmacy space is (14.7mX17m). Additional space is required. 
Essential and core hospital pharmacy practices that are not existing are 
as follows: 
• Unit dose distribution system 
• IV admixture program 
• Total parentral nutrition services   
• Drug information and education services 
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• Therapeutic drug monitoring services 
• Quality improvement program 
• Pharmacy computerization 
 
Form the survey results and the site visit findings it is clear that Soba 
university Hospital pharmacy required to be brought up to the minimum 
standards required for hospital pharmacy practice. In addition to 
implementation of pharmaceutical care best practices to serve a leading role 
for pharmacy profession and enable pharmacists to perform pharmacy clinical 
services is recommended. 
This requires expanding and upgrading of the current pharmacy, in 
addition to provision of pharmaceutical care services based on evidence based 
pharmacy practices to enable Soba pharmacy to serve as model for the modern 
pharmacy practice and play a key role in upgrading pharmacy profession. 
As a result of this study, the pharmacy was refurbished and financial 
support was offered to complete the project. Many parties participated in the 
progress of this project including, University of Khartoum, Faculty of 
Pharmacy, Soba administration, Sudan central medical supplies and concerned 
pharmacists. 
The officials at the Faculty of Pharmacy continued their effort in 
providing success toward the completion of the project through follow-up and 
communication with different organizations, companies to provide financial 
support. 
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3.4 Future Perspectives 
 
Examples of the services that can be provided at Soba Hospital are: 
3.4.1 Pharmacist managed anticoagulant clinic 
Patients taking anticoagulants need to be concerned about problems that 
could arise if they take new medicines or change their diet while on 
anticoagulants. There are many medical conditions that increase the chance of 
a blood clot forming in the body (Harish et al, 1988; Walker ID, 1998 and 
Holbrook, 1996). Pharmacist-managed anticoagulation services have been 
developed to assist physicians in the individualized dosing and monitoring of 
anticoagulant therapies such as heparin and warfarin to provide consistent 
mechanism for assessment, education and monitoring patients on 
anticoagulation medications by a clinical pharmacist (Choe et al, 2002 and 
Brown 2003).  
The Objectives of the clinic are to maximize the benefits of 
anticoagulation therapy, reduce adverse effects and complications resulting 
from anticoagulation therapy, assist physicians in the management of patients 
placed on anticoagulation drug therapy, serve as an information resource for 
patients enrolled in the anticoagulant clinic, provide educational programs and 
in-services to medical, nursing, and pharmacy staff regarding various aspects 
of anticoagulation therapy, conduct research regarding anticoagulation therapy 
and related areas and serve as an educational site for students, pharmacy 
practice residents, specialty residents, and fellows. (Lee YP and Schommer 
JC, 1996; Macgregor et al, 1996; Piwowar et al, 1996; Radley et al, 1995; 
Pubentz MJ et al, 1998 and Choe et al, 2002). This will lead to better 
knowledge of concomitant disease and drug therapy and better continuity of 
care, better use of physician and patient time and improved disease control.  
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Point-of-care (POC) testing devices for PT-INR 
Various POC coagulations testing devices (Coagulometers) are 
commercially available. It allows more convenient testing of warfarin therapy 
and improved management of anticoagulation not only in anticoagulation 
clinics but also in patient homes. Results can be obtained within 2-3 minutes. 
The POC PT-INR is a well established test to monitor warfarin in 
anticoagulation clinics (Fitzmaurice and Machin, 2001; (Blann et al, 2003; 
Spinler et al, 2005 and Ansell et al, 2001) 
Staffing  
Often the anticoagulation clinic is coordinated by a clinical pharmacist 
under the supervision of a practitioner; clinical pharmacists are ideal 
candidates for such a role because they have an extensive knowledge of 
pharmacokinetics, pharmacodynamics, drug–drug (including herbals & over 
the counter drugs) and drug-food interactions. 
Staff training is vital and should be carried out. The in charge 
pharmacist should develop standard operating procedures for the clinic and 
provide on-going education and training for all staff working in the clinic; 
health and safety policies will also be required. (Radley et al, 2000) 
Clinic references and materials 
The anticoagulation clinic will maintain the following; materials 
necessary for anticoagulation management, the most recent recommendations 
and guidelines for anticoagulation therapy, a list of the most common warfarin 
drug interactions for easy access and patient anticoagulant record cards, 
education materials and patient profiles (either computerized or paper 
documents) (Coleman et al, 2003). 
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Service audit  
Quality improvement measures are essential to service development and 
improvement. e.g.  All treatment failures or hemorrhagic events should be 
documented, improved patient knowledge and satisfaction with the service 
should be assessed using simple questionnaires, staff competence should be 
assessed regularly and an error reporting system put in place.  
3.4.2 Therapeutic drug monitoring (TDM)  
 
Therapeutic drug monitoring (TDM) is a tool that can guide the 
clinician to provide effective and safe drug therapy in the individual patient. 
Monitoring can be used to confirm a plasma drug concentration which is 
above or below the therapeutic range, thus minimizing the time which elapses 
before corrective measures can be implemented in the patient. (Longa and 
Cross, 1984) 
The basic goal of therapeutic drug monitoring (TDM) is to enhance the 
patient's chance of maximum benefit from a prescribed drug while minimizing 
the risks of toxicity. Characteristics of drugs associated with TDM are narrow 
therapeutic range, unpredictable dose/response relationship, significant 
consequences from toxicity, correlation between serum drug concentration 
(SDCs) and efficacy or toxicity and readily available assays (Brikett 1997 and 
Schumacher and Barr, 1998).   
Indications 
Therapeutic drug monitoring is indicated in clinical situations in which 
an expected therapeutic effect of a drug has not been observed or in cases 
where drug toxicity related to high toxic serum drug concentration (SDC) is 
suspected (Walson, 1998). In addition, TDM can be used to establish whether 
or not optimum therapeutic drug concentrations have been achieved for drugs 
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characterized by a response that is difficult to detect or in which the 
manifestations of disease are life threatening and the trial and error approach 
to modification of dosing regimen is unacceptable. In situations in which 
chronic drug administration is expected, TDM can be used to define the 
effective target SDC in the patient. The target SDC can then be used if 
pharmacokinetics change in the patient over the course of chronic drug 
administration is due to disease, environmental changes, age or drug 
interactions (eg, phenobarbital). Drug monitoring has also been useful in 
identifying patient noncompliance as a cause of therapeutic failure or adverse 
reactions (Gross, 1998 and Thomson, 2004). 
In addition, TDM is indicated when a drug is used chronically, and thus 
is more likely to induce toxicity or changes in pharmacokinetics (i.e., 
anticonvulsants), or in life-threatening situations in which a timely response is 
critical to the patient (e.g., epilepsy or bacterial sepsis) (Binder et al, 1998).  
TDM Process  
Figure 3.19 provides the pharmacist based therapeutic drug monitoring.   
 
Figure 3.19. TDM process 
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3.4.3 Parentral nutrition (PN)  
Parentral nutrition (PN) is the provision of intravenous nutrients to 
patients whose gastrointestinal (GI) tract is not functioning or cannot be 
accessed and to patients whose nutritional needs cannot be met with oral diets 
or enteral tube feeding. PN has provided lifesaving therapy for patients who 
could not otherwise be nourished. Because of its complexity, PN therapy 
requires careful monitoring by trained clinicians to avoid serious 
complications (Khalidi et al, 2003).  
Ordering PN formulations 
Many of the errors associated with the use of PN formulations are 
related to the complex nature of the ordering process. Clinical errors have 
been associated with the manner in which orders were created and 
communicated and lack of uniformity in the ordering process from institution 
to institution. Standardizing the order-writing process has been shown to 
reduce prescribing errors. The PN order form should be simple, the trailing 
zeroes should never be used, units of measures should be consistent between 
the order form and PN label format, ingredients should be listed in the same 
manner on the PN order form and PN label format. (Jacobs, et al 2002 ; 
Mirtallo et al, 2004 ; Kumpf et al, 2005 and Forchelli and Miller, 2005). A 
simple and uniform PN order form is required, a sample for the PN order form 
(Appendix G) is provided.   
Labeling PN formulations  
The way TPN ingredients are labeled varies considerably. PN base 
components (dextrose, amino acids, and lipids) have been labeled as the 
volume of the percent of original concentration added, the percent of final 
concentration after admixture, and either the grams per liter or the grams per 
total volume of TPN admixed. Additives, especially electrolytes, have been 
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labeled as mEq or mmol and as quantity per day, per kg, per liter, or per 100 
mL.  
The new recommendation suggests the labeling of total grams of base 
and total mmol/mEq of electrolytes per day (Mirtallo et al, 2004 and Kumpf et 
al, 2005). Sample provided (Appendix H) 
PN access and infusion equipment  
The development of central venous access devices is closely linked to 
the development of TPN. Today, the use of central venous access has become 
a standard for a multitude of intravenous (IV) therapies. Vascular access is 
both an art and a science. Decisions and practices related to device selection, 
placement, and maintenance as well as appropriate use of infusion systems 
affect the success of parenteral nutrition administration (Krzywda and 
Edmiston, 2005). 
Therefore the following equipment issues are also important; 
• Central venous access types and selection. 
• Central venous catheter knowledge of placement to the patient. 
• Central venous catheter care and maintenance to avoid infections. 
• Suitable peripheral access devices types  
• Infusion delivery types and selection criteria. 
Monitoring and management of PN  
Serious complications can be associated with PN administration. The 
potential for serious complications with PN is unacceptably high unless 
careful monitoring is conducted by experienced clinicians. (Mirtallo et al, 
2004; Khalidi et al, 2003 and Sacks et al, 2005). Monitoring by experienced 
clinicians can control costs and minimize complications. 
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Complications of PN 
Although widely reported, complications of PN can be minimized when 
a “multidisciplinary team” of trained professionals monitors PN therapy and 
venous access devices. (Khalidi et al, 2003 and Sacks et al, 2005) 
Quality assurance  
Parenteral nutrition is a complex therapy with a lot of considerations 
and potential complications which necessitates the importance of quality 
assurance process. Formal training program must be in place and the 
pharmacists who participate in parenteral nutrition program pass competency 
exams. (Adams, 2000). Continuous quality improvement is necessary to 
ensure that patients on PN, who are managed by pharmacists, receive the 
highest quality of care. e.g. patient charts review on regular basis for number 
of interventions, blood glucose control, electrolyte levels and clinical 
outcomes. 
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PN Therapy Management Process  
Figure 3.20 illustrates the PN management process (Mirtallo et al, 2004; 
Khalidi et al, 2003 and Sacks et al, 2005).  
 
Figure 3.20. PN therapy management process 
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4.4.4 Medication reconciliation  
Medication conciliation is a process of comparing what the patient is 
taking at the time of admission or entry to a new setting with what the 
organization is providing to avoid errors of transcription, omission, 
duplication of therapy, drug-drug and drug-disease interactions, etc. 
Medication reconciliation is  as a process of obtaining a complete and accurate 
list of each patient’s current home medications—including name, dosage, 
frequency, and route—and comparing the physician’s admission, transfer, 
and/or discharge orders to that list. Discrepancies are brought to the attention 
of the prescriber and, if appropriate, changes are made to the orders. Any 
resulting changes in orders are documented. (IHI, 2007) 
The case for medication reconciliation 
Medication errors are one of the leading causes of injury to hospitalized 
patents and chart reviews reveal that over half of hospital medications errors 
occur at the interface of care, 50% of all medication errors and 20% of ADEs 
in the hospital is due to poor communication of medical information at 
transition points (Rozich and Resar, 2001). 
A multidisciplinary check of medication orders for pediatric patients in 
a cancer center in USA, revealed that 42% of orders being reviewed needed to 
be changed. (Branowicki, 2002)  
The medication reconciliation has been demonstrated to be a powerful 
strategy to reduce medication errors as patients move form one level of care to 
another. A series of interventions, including medication reconciliation 
introduced over a period of 7 months successfully decreased medication errors 
by 70% and reduced adverse drug events by over 15% (Whittington and 
Cohen, 2004). 
 
120 
 
Medication reconciliation process 
An up –to date and accurate medication list is essential to ensure safe 
prescribing and to prevent adverse drug events (ADEs). (IHI, 2007) 
The process involves three steps:  
1. Verification (collection of medication history).  
2. Clarification (ensuring that the medications and doses are 
appropriate). 
3. Reconciliation (documentation of changes in the orders).  
Figure 3.21 illustrated the process steps (IHI, 2007 and Rich Darryl 
S, 2006) 
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Figure 3.21.  Medication reconciliation process 
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4. CONCLUSIONS AND RECOMMNDATIONS 
 
4.1 Conclusion 
Pharmaceutical care best practices in Khartoum State are severely 
compromised. The minimum standard for hospital pharmacies is considerably 
deficient. 
The practice management standard for the surveyed hospitals in 
Khartoum State was compromised which affects the delivery of 
pharmaceutical care services. Staffing is not adequate to perform the existing 
functions and activities which are already compromised and not up to the 
minimum standard of pharmaceutical care best practice.  
The pharmacists are not able to play their role of drug information 
provision to health care providers; however, provision of drug information for 
patients was better but still compromised. 
Optimizing of medication therapy standard which reflects the 
pharmaceutical care vision, direct patient care and clinical services is 
significantly underprovided. These processes, functions, activities, programs 
and services need to be brought up to the minimum required standard. 
Pharmaceutical care vision must be considered, structured clinical services 
have to be developed and processes have to be re-engineered.   
The prime responsibility of pharmacy is to control and distribute 
medications within the hospital. Based on the analysis of the best practices in 
Khartoum State, this standard lacks many core elements, services and 
processes. Redesigning of pharmacy systems is required to bring this standard 
up to the optimum requirement.  
Facilities are essential for implementation of best practices and 
provision of pharmacy administrative, operational and clinical functions. 
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Equipment is required for packaging and compounding of medications, IV 
admixture program and other pharmacy functions. Information resources are 
essential for provision of drug information. The analysis of best practices in 
Khartoum State survey indicated that the space is not enough to fit the existing 
services. Space is a success factor for best practices implementation and 
should be considered when redesigning the pharmacy services. Hospitals 
administration and concerned bodies should support pharmacy departments to 
avail and provide adequate space to fit the proposed best practice services. 
Equipment is the second success factor for best practices 
implementation. All equipment needed for pharmaceutical care best practices 
implementation must be made available. 
Resources and space are required for provision of drug information 
especially electronic resources. 
Drug distribution and control is the prime responsibility of pharmacy 
including the investigational drugs. Survey analysis indicated that the research 
standard is lagging behind. Policies and procedures for safe and proper use of 
investigational drugs should be developed and followed, in addition to 
dispensing and controlling of all investigational drugs by the pharmacy. 
Pharmaceutical care best practices in Soba Hospital are severely 
compromised. The minimum standard for hospital pharmacies is considerably 
deficient. Two standards out of the 6 minimum standards for hospital 
pharmacies do not exist, namely drug information and education and 
investigational medications standard.  
Essential and core services do not exist, namely unit dose distribution 
system, IV admixture program, total parentral nutrition services, therapeutic 
drug monitoring services, quality improvement program, pharmacy 
computerization, medication error reporting program and adverse drugs events 
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reporting program. In addition to best practices required to build a safe 
medication management and use system. e.g. do not use abbreviations, look 
alike and sound alike medications and high alert medications management 
plan. 
Pharmacists and pharmacy services bear professional responsibility for 
the medication management and use activities in hospitals. The overall 
pharmacy function and role will continue to include but not limited to: 
• Leading development of the medication management and use policies 
and procedures, including pharmacy and therapeutics committee 
policies and therapeutic protocols. 
• Reviewing and verifying individual patient’s medication orders and 
prescriptions for safety and effectiveness of therapy. 
• Educating patients and health care providers about medications and 
their use. 
• Leading improvements in the quality of the medication management 
and use. 
• Procuring quality medications products from quality and trusted supply 
sources. 
• Preparing medications in doses and dosage forms as required. 
• Dispensing medications to outpatients and inpatients. 
• Assigning staff in clinical and other functions to ensure effective, safe, 
appropriate and optimal patient care. 
• Providing up-to-date drug information to health care providers. 
• Conducting quality reviews of medication utilization 
• Influencing decisions about medications related informatics and 
automated processes in medication management and use.   
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Pharmaceutical care is applicable and achievable by pharmacists in all 
practice settings, not only to pharmacists with certain degrees, specialty 
certifications, and residencies or other. It is not limited to those in academic or 
teaching settings. Pharmaceutical care is a matter of direct personal, 
professional, responsible relationship with a patient to ensure use of 
medication is optimal and leads to improvements in the patient’s quality of 
life. 
The commitment of pharmacists to the achievement of definite 
outcomes for individual patients and acceptance of the responsibility for 
individual patients’ outcomes represents a significant advancement in the 
pharmacy profession and is the natural evolution of more clinical pharmacy 
activities of pharmacists. Developing of recognized methods of practicing 
pharmaceutical care is an important priority for the profession. 
The pharmaceutical care concept does not diminish the roles and 
responsibilities of other health professionals. Pharmacist’s actions in 
pharmaceutical care should be conducted and viewed collaboratively. 
Pharmaceutical care represents a new vision for pharmacy. All 
pharmacists should share this vision and this will serve as stimulus for them to 
work toward changing the pharmacy profession to actualize that vision. 
To bring the pharmacy profession up to the required standard in Sudan, 
collaboration of officials at the Schools of Pharmacy, Ministry of Health, 
hospitals, official bodies such as Pharmacy and Toxicology Federal Council 
and Sudan Pharmacist Union, and pharmacists themselves is required. 
All hospital pharmacies must adhere to the minimum standards and 
avail the resources for best practices implementation.  
 
 
126 
 
4.2 Recommendations 
 
Best practices recommendations – National/Pharmacy schools levels  
• The officials and governing bodies should support and enforce   
implementation of pharmaceutical care best practices.  
• Pharmacy educators must teach pharmaceutical care to students. 
• Curricula should be redesigned to produce graduates with sufficient 
knowledge and skills to provide pharmaceutical care competently. 
• Continuing education providers should help pharmacists to understand 
the  pharmaceutical care and best practices concepts.  
• Research is needed to evaluate various methods and systems for 
delivery of pharmaceutical care and best practices. 
Best practices recommendations - Hospital/pharmacy level 
The following recommendations can be implemented by hospitals. They 
focus on standardization, simplification of medication system processes, 
changes to existing hospitals systems and a continual focus on improvement. 
Implementation of unit dose systems 
Maintain and systematically use unit-dose distribution systems for all 
non-emergency medications throughout the hospital.   
Establishment of pharmacy- based IV admixture systems 
• Availability of space and equipment for compounding of sterile 
products.  
• Preparation and labeling of all sterile products in a clean room under 
aseptic technique by appropriately trained personnel. 
• Development and maintenance of quality improvement procedures for 
preparation of sterile products. 
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Availability of up-to-date drug information 
• Provision of drug information to perceive and evaluate the drug 
information needs of patients and families, health care professionals and 
other personnel. 
• Establishment and maintenance of a hospital formulary 
• Development of medication use evaluations and drug monographs. 
• Publication of newsletters to educate patients and families, health care 
professionals and other personnel. 
• Coordination of the investigational drug services. 
• Education of pharmacy students and residents. 
• Development and maintenance of an active research program. 
• Revision of error potential for all new products, including a literature 
review, before any drug or procedure is approved for use.  
Education and training of staff 
• Provision of physicians, nurses, pharmacists, and all other clinicians 
involved in the medication use process with orientation and periodic 
education on ordering, dispensing, administering, and monitoring 
medications. 
• Provision of pharmacists and pharmacy technicians with relevant 
continuing education as necessary to maintain and enhance their 
competence. 
• Distribution of benchmarks for pharmaceutical care best practices from 
different institutes. 
• Provision of pharmacy technicians with training, especially for IV 
admixture preparations and medication management and use as general.    
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Patients’ education 
• Patients should be educated in the hospital, at discharge, and in 
outpatient settings about the safe and proper use of heir medications.  
• Encouragement of patients to ask questions about their medications.  
• Encouragement of health care providers to work with pharmacists on 
patient education when patients receive certain classes of medications 
or are discharged on more than five medications.  
Availability of pharmacy expertise 
Make the pharmacist more visible in patient care areas through: 
• Having pharmacists make daily rounds on units 
• Having pharmacists enter orders directly into computer terminals in 
patient care units.  
Building of a safe medication use system 
1. Development of special procedures and written protocols for high-alert 
drugs 
• Use of written guidelines, checklists, dose limits, pre-printed orders, 
double-checks, special packaging, special labeling, and education. 
• Limitation of the number of possible concentrations for a drug, 
particularly high-alert drugs. Such standardization will allow the use of 
premixed solutions from manufacturers or from centralized preparation 
of IV medications in the pharmacy. 
2. Standardization of prescribing, communication practices and multiple 
processes:  
• Avoidance of certain dangerous abbreviations; identify a list of 
prohibited abbreviations that will not be used.  
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• Inclusion of all elements of the order – dose, strength, units, route, 
frequency, and rate.  
• Use of full names (preferably generic).  
• Use of computerized reminders for look-alike and sound-alike drug 
names.  
• Use of preprinted order sheets whenever possible in non-computerized 
order systems. 
• Use of protocols for the use and storage of high-alert drugs 
Optimization of the medication therapy 
Optimize the medication therapy by developing and implementing 
structured clinical services to promote better patient outcomes. 
• Documentation of actions and recommendations by pharmacist in 
patient medical record. 
• Development of an on-going process for consistent documentation of 
pharmaceutical care and patient outcomes. 
• Development of a total parentral nutrition program 
• Development of an on-going therapeutic drug monitoring program. 
• Reconciliation of patient medications at admission, transfer and 
discharge 
Development of an on-going program for monitoring, reporting and 
prevention of adverse drug reactions 
• Assessment of the safety of drug therapies, especially new ones. 
• Education of health professionals and increase their level of 
awareness regarding adverse drug reactions. 
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• Identification and measurement of trends and institute corrective 
actions designed to improve patient outcomes by minimizing 
potential adverse drug reactions. 
• Provision of quality assurance/improvement initiatives in medication 
use. 
 
Development of a voluntary system to monitor and report adverse drug 
events 
• Review of policies for how your organization encourages reporting and 
analyzing medication errors throughout the hospital.  
• Encouragement of candid communication and feedback.  
• Ensure no reprisals for reporting of medication errors. Reports will 
increase if you make it safe to report. 
• Medication errors reporting outcomes should be used as an educational 
quality tool. 
Increase the use of computers in the medication use system  
• Plan for the implementation of computerized prescriber order entry 
systems when technically and financially feasible in accordance to the 
hospital resources and technological development. 
• Use of computerized drug profiling in the pharmacy. 
• Use of pharmacy system software with an automatic alerts and checks 
for:  
1. Allergy checking  
2. Duplicate therapy checking  
3. Drug-Drug interactions  
4. Food-Drug interactions  
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5. Geriatric/pediatric warnings  
6. Pregnancy/lactation warnings  
7. Renal precautions based on ClCr 
8. Usual dosage ranges  
• Encouragement of the use of computer-generated or electronic 
medication administration records.  
• Consideration the use of bar coding in the medication administration 
process.  
 
Voluntary accreditation 
• Accreditation provides a visible commitment by an organization to 
improve the quality of patient care. 
• Accreditation ensures safe environment and continuous work to reduce 
risks to patient and staff. 
• Accreditation is an effective quality evaluation and management tool.  
 
Use of best practices self assessment tool 
• Development of best practices self assessment tool 
• Assessment of facility situation  
• Improvement of the deficient or compromised practices. 
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(Appendix A) 
 
 
Best Practices Assessment Survey 
 
Hospital name:  ________________________________ No. of beds __________ 
Type of care provided?    Primary care        Secondary care         Tertiary/Acute care  
Filled by: ___________________________ Title:  ______________________________ 
Contact No.: _________________________ E-mail:_____________________________ 
 
Practice management 
 
Yes  No Comments 
if any 
1. The pharmacy has a written mission statement that is consistent with the mission of the 
hospital. 
   
2. A continuing education program for the pharmacy staff exists. 
 
   
3. An established orientation program for the new arrivals to the hospital, pharmacy and 
respective positions exists.  
   
4. Procedures for the evaluation of the staff performance exists 
 
   
5. Written job descriptions for all categories of the pharmacy staff exists. 
 
   
6. Policies and procedures covering administrative functions exist.  
 
   
7. A process exists to routinely monitor pharmacy workload 
  
  
8. Pharmacist participate in the committees responsible for provision of patient care  
 
   
9. The pharmacy has sufficient staff to perform required functions and responsibilities 
 
   
10. 24 -hours pharmacy coverage exist. 
 
   
11. When 24- hour coverage is absent, on call pharmacist is available.  
 
   
12. A disaster plan exists for providing pharmaceutical care in case of disaster event. 
 
   
13. The pharmacy is responsible for product specifications, procurement, distribution, and 
control of all drugs used within the hospital.  
   
14. A quality improvement plan for the pharmacy exists.   
 
 
   
Drug information and education 
 
Yes No Comments 
if any 
15. Up-to-date drug information exists. 
 
   
16. Medication-therapy monographs for the medications under consideration for the formulary 
addition or deletion are available.  
   
17. Pharmacists actively participate in patient education. 
 
   
18. Pharmacists keep the hospital staff informed about the use of medication on an on-going 
basis through appropriate publications, presentations & programs. 
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Optimizing medication therapy  
 
Yes No Comments 
if any 
19. Policies and procedures covering clinical functions exist. 
 
   
20. Clinical actions and recommendations by pharmacist were documented in patient medical 
record. 
   
21. Pharmacists have an access to medication histories    
22. All medications orders are verified and reviewed for appropriateness by a pharmacist 
before dispensing. 
   
23. Medication orders clarification and intervention should be documented either at the patient 
medical record or the pharmacy copy of the medication order 
 
   
24. A medication use evaluation (MUE) program exists to ensure that medications are used 
appropriately, safely and effectively. 
   
25. An ongoing process for consistent documentation of pharmaceutical care and patient 
outcomes exists. 
   
26. Pharmacists are involved in the development of clinical care plans involving medication 
therapy. 
   
27. A total parentral nutrition program exists. 
 
   
28. An on-going therapeutic drug monitoring process is available 
 
   
29. Patient education and counseling program exists. 
 
   
30. There is a computerized pharmacy system in place. 
 
   
Medication distribution and control 
 
Yes  No  Comments 
if any 
31. Policies and procedures covering operational functions exist. 
 
   
32. A formulary of approved medications for use at the hospital is maintained by the 
pharmacy. 
 
   
33. Medications are prescribed by individuals who have prescribing privileges    
34. Drug formulations which are not available commercially shall be prepared by pharmacy 
against evidence based references. 
   
35. Pharmacy keeps and maintains patient’s medications profiles. 
 
   
36. All sterile products were prepared and labeled in a clean room  
      under aseptic technique by appropriately trained personnel. 
   
37. Quality assurance procedures for the preparation of sterile products exist. 
 
   
38. Unit dose is the drug distribution system 
 
   
39. Medications are stored under proper conditions of sanitation, ventilation, temperatures, 
light, moisture, 
   
40. Medications are stored under proper conditions of security. 
 
   
41. An on-going program for monitoring, reporting and preventing adverse drug reactions 
exists. 
   
42. An on-going program for monitoring reporting and preventing of medication errors exists.    
43. A list of (do not use abbreviations and dose designations) should exist. Medications orders 
and prescriptions containing such abbreviations are not accepted by pharmacy.  
   
44. A high alert medication management plan exists  
 
   
 3 
45. An established process and written policy for drug product recalls exists. 
 
   
46. Guidelines for the use of the patient’s “own medication” while at the hospital exists. 
 
   
47. Guidelines for the use of drug samples exist. 
 
   
48. Accountability procedures for the controlled drugs exist. 
 
   
49. All medication storage areas are inspected routinely to ensure absence of expired items.    
50. Floor stocks are limited to emergency medications and safely used items (e.g., 
mouthwashes, disinfectants and antiseptic solutions). 
   
Facilities, equipment and information resources   
 
Yes No Comments 
if any 
51. Facilities for medication storage are available.  
 
   
52. Designated space and equipment for packaging and compounding of medications exists.    
53. Designated space and equipment for compounding of sterile products exists. 
 
   
54. Adequate space, resources are available to facilitate provision of drug information. 
 
   
55. A private area for patient counseling and education exists. 
 
   
56. Offices for administrative activities are available. 
 
   
57. Adequate space for storing records, files and stationeries exists 
 
   
58. Meeting area for administrative, educational and training activities is available. 
 
   
Investigational medications Yes  No  Comments 
if any 
59. Policies and procedures for safe and proper use of investigational medications are 
developed and followed 
   
60. Pharmacy distributes and controls all investigational drugs 
 
   
 
Please describe the pharmacy procedures for dispensing the medications to the 
hospitalized patients (Drug distribution system)? 
 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
 
 *Adapted from the minimum standards for pharmacies practices in hospitals (ASHP, 
1995; Manitoba, 2004 and JCIA, 2007). 
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Appendix B 
 
DRUGS THAT LOOK ALIKE AND SOUND ALIKE  
       
Acetohexamide  Acetozolamide   Leukeran Alkeran 
Amaryl  Reminyl   Lasix Lidex 
Amlodipine Amiloride  Lasix Losec 
Amphotericin B  Ambisome   Lipostat Lipitor 
Celexa  Celebrex   Losec Mobic 
Chlorpropamide  Chlorpromazine   Metolazone Methimazole 
Cisplatin Carboplatin  Metoprolol Metaproterenol 
Clomifen Baclofen  Morphine Hydromorphone 
Clonidine  Clonazepam   Myambutol Nembutal 
Coumadin Codeine  Neupogen Neumega 
Diabeta  Zybeta   Niacin Minocin 
Diclofenac Diflucan  Nilstat Nitrostat 
Diclofenac Duphalac  Norpramine Imipramine 
Dilantin Diltiazem  Noroxin  Neurontin  
Dimenhydrinate Diphenhydramine  Panadol Paracodol 
Dipyridamole Disopyramide  Panadol Parlodel 
Dobutamine Dopamine  Paxil Plavix 
Doxorubicin  Daunorubicin   Paxil Taxol 
Daunorubicin Idarubicin  Penicillin Penicillamine 
Dyazide Diazoxide  Physostigmine Prostigmine 
Dyrenium Pyridium  Physostigmine Pyridostigmine 
Enalapril Anafranil  Pralidoxime Pyridoxine 
Ephedrine Epinephrine  Prednisone Prednisolone 
Esidrex Lasix  Prilosec Prozac 
Feldene Seldane  Priscoline Apresoline 
Fentanyl Sufentanil  Procarbazine Dacarbazine 
Folic acid Folinic acid  Ranitidine Ritodrine 
Gamastan Garamycin  Retrovir Ritonavir 
Garamycin Kanamycin  Sandimmune Sandostatin 
Garamycin Terramycin  Sandostatin  Syntocinon  
Gilipizide Gliclazide  Stelazine Selegline 
Halotestin Halothane  Taxol Taxotere 
Humalog Humulin  Temadol Tramal 
Hydralazine Hydroxyzine  Tobrex  Tobradex  
Imuran Inderal  Tolazamide Tolbutamide 
Imuran Imferon  Tolazamide Tolazoline 
Imuran Imovane  Tretinoin Trientine 
Inderal Medrol  Tylenol Timolol 
Infliximab Rituximab  Vincristine Vinblastine 
Interferon Imferon  Wycillin Bicillin 
Isoptin Intropin  Xenical  Xeloda  
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Isordil Isuprel  Zantac Xanax  
Lamisil Lamictal  Zantac Zyrtec  
Lamivudine lamotrigine  Zyrtec  Zyprexa 
Lantus Lente  Zyprexa Celexa  
Leukeran  Myleran   Zestril Staril 
Leukeran  Leucovorin calcium  Zostrix Zovirax 
 
References: ISMP Medications Safety Alert 7/(12) June, 12, 2002 
                     JCAHO Sentinel Event A. Issue 19-May 2001  
 
Appendix C 
 
Dangerous Abbreviations list 
Abbreviation Intended meaning Common Error 
U Units 
Mistaken as a zero or a four (4) resulting in 
overdose. Also mistaken for "cc" (cubic 
centimeters) when poorly written. 
µg Micrograms Mistaken for "mg" (milligrams) resulting in 
an overdose. 
Q.D. Latin abbreviation for every day 
The period after the "Q" has sometimes been 
mistaken for an " I, " and the drug has been 
given "QID" (four times daily) rather than 
daily. 
Q.O.D. Latin abbreviation for every 
other day 
Misinterpreted as "QD" (daily) or "QID" 
(four times daily). If the "O" is poorly 
written, it looks like a period or "I." 
SC or SQ Subcutaneous Mistaken as "SL" (sublingual) when poorly 
written. 
T I W Three times a week Misinterpreted as "three times a day" or 
"twice a week." 
D/C Discharge; also discontinue 
Patient's medications have been prematurely 
discontinued when D/C, (intended to mean 
"discharge") was misinterpreted as 
"discontinue," because it was followed by a 
list of drugs. 
HS Half strength Misinterpreted as the Latin abbreviation 
"HS" (hour of sleep). 
cc Cubic centimeters Mistaken as "U" (units) when poorly written. 
AU, AS, AD Latin abbreviation for both 
ears; left ear; right ear 
Misinterpreted as the Latin abbreviation 
"OU" (both eyes); "OS" (left eye); "OD" 
(right eye) 
IU International Unit Mistaken as IV (intravenous) or 10(ten) 
MS, MSO4, 
MgSO4 Confused for one another 
Can mean morphine sulfate or magnesium 
sulfate 
 
* This list is a minimum list recommended by joint commission international for 
accreditation (JCIA), the list can be expanded. (McEvoy, 2005) 
 
Appendix D 
 
ADVERSE DRUG REACTION (ADR) FORM 
I. HEALTHCARE PROVIDERS           
Patient's Information or Label Containing Information Below       
Name:_____________________________ Sex:______________________________   
Medical Record Number:_______________ Age:______________________________   
Admission Date:_____________________ Allergies: __________________________   
Ward:_____________________________ Attending physcian:____________________   
Diagnosis:__________________________       
Adverse Events or Product Problem: 
1. Suspected Drugs:             
1-        
2-           
2. Reaction Description   
Date Started & 
Time:       
           
3. Outcomes (Check all that applies)           
□ Hospitalization - initial or prolonged  
□ Congenital 
anomaly     
□ Required intervention to prevent permanent □ Life threatening     
 impairment/damage   □ Death  _______________ (day/mo/yr)   
□ Disability    □ Other:  ____________    
                  
Reporter Name Title Contact Number Date & Signature 
                  
        
II. FILLED BY PHARMACISTS           
Suspected Medication(s): Give brand name if known 
Name Route  Dose Freq. Therapy Dates Indication Lot # Expiry 
                
Suspected Concomitant Medication/ Therapy: (Includes self-medication) 
Name Route  Dose Freq. Date Started 
Date 
Stopped 
  Indication 
              
              
Relevant History: (e.g. Medical history, allergies, race, etc) Relevant tests/laboratory data, including dates: 
             
             
Description Notes               
                
           
Classification:          Preventable?    
□ Adverse Drug Reaction □ Documented but avoidable       
□ Allergy / Hypersensitivity □ Undocumented Naranjo Score:_________________________ 
□ Underlining Disease State 
□ Documented and avoidable 
because        
□ Exaggerated Drug Effect Severity Level:_________________________ 
□ Idiosyncratic Reaction             
Reporting Pharmacist     Date & Signature: 
                 
* Adapted from Naranjo, et al, 1981. 
Appendix E 
Medication Error Report Form 
Patient #___________                     Name______________________________________ 
Location____________                                      
Age______________                                                              
 
Date of occurrence:  ____________________ Time: ____________                  
Discovered by:    Physician    Pharmacist     Nurse     respiratory Therapist      other 
____________________   
Summary of event:  
 
 
 
Name of drug: _______________________________   Dose: ______________ 
 
Medication Order (as written):  _______________________________________ 
 
Classification:  
  No error occurred; reporting circumstances which may lead to a potential error (complete ‘stages’ and 
describe above). 
  Medication-related discrepancy; error was identified but medication did not reach the patient. 
  Medication related incident; error was identified but medication did reach the patient.  (complete 
‘consequences’ section which follows) 
 
  Consequences:    
       no harm to patient   monitoring / 
intervention to prevent 
harm was required 
  patient suffered 
temporary harm that 
required intervention 
  patient suffered 
temporary harm 
requiring 
hospitalization 
 permanent patient   
        harm 
  required life-saving 
intervention 
  contributed to patient 
death 
 
 
 Intervention: 
       administered antidote   appropriate frequency was 
re-instituted 
  change to correct dosage 
       change to correct drug   no intervention was 
necessary 
  
others________________________ 
Type of error: 
  omission of dose   wrong dose   wrong drug   wrong dosage form 
  extra dose given   too high (pt 
overdosed) 
  wrong 
strength/concentration 
  wrong administration 
route/rate 
  wrong time 
 others 
__________________ 
  too low (pt 
underdosed) 
  wrong patient   expired drug 
 
Stages involved: 
  prescribing   transcribing / order 
entry 
  dispensing / 
delivery 
  
administration 
  monitoring 
Analysis 
  non-formulary drug(s) involved?   drug(s) used in the operating room?   drugs from ward stock? 
  drug sample(s) involved?   drug(s) used in the emergency room?   intravenous solution 
involved? 
  chemotherapy drug(s) involved?   infusion devices involved?   complimentary therapy? 
  pediatric drug(s) involved?   drugs in multidose container?   None of the above  
*Adapted from Manasee  and Thompson, 2005).  
Given as: 
 
 
 
How many doses?   _______ 
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Appendix F 
Equipments specifications for Soba pharmacy Expansion 
 
Unit dose tablet manufacturing machine 
No  Description  
1 Requirements to be met: 
1.1 To prepare tablets & capsules in unit dose strips for single dose administration.  
1.2 Able to pack 55 units per minute or better. 
1.3 Have a computer controlled printing system.  
1.4 With manual fill universal capsule and tablet disks for feeding. 
2 Accessories:  
2.1 PC Latest compatible with the Machine  
2.2 Latest software & cables 
2.3 Disk & chute kits, Cleaning brushes 
3 Consumables:  
3.1 Supply of all the standard consumables for start-up including labels 
3.2 Foils & strips of various sizes 
Unit dose liquid dispensing machine 
No  Description  
1 Requirements to be met: 
1.1 To prepare the oral liquid ready to use unit dose Pedi     -pods for single 
administration   
1.2 Fully automatic & have a variable speed  
1.3 Maximum speed not less than 30 units per minute 
1.4 Have a computer controlled printing system 
2 Accessories:  
2.1 PC Latest compatible with the Machine  
2.2 Latest software & cables 
2.3 Supplied with all standard accessories 
3 Consumables:  
3.1 Supply of all the standard consumables for start-up including labels 
3.2 Cups of different sizes with lids 
Unit dose cassettes 
No Description 
1 Requirements to be met: 
1.1 Unit dose medication cart made of high-density polyurethane 
1.2 Able accommodate a replaceable type of one single piece cassette of 20 bins 
1.3 Bin size approx. L 30 cm x W  10-12 cm x D 8 cm 
1.4 Bin should have space for clear plastic inserts for labeling  
1.5 Rest of the cart supplied with 3 full size draws. For storage of syringes and other 
patient needed consumables. 
1.6 Supplied with bumper bridges 
1.7 Mobile on wheel with non-marking anti-static lockable castors 
1.8 Cassette bins are lockable with minimum 2 keys (Metal), plus security locking 
platform 
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2 Accessories: 
2.1 Supplied with all accessories 
3 Consumables:  
3.1 Supplied with all consumables 
Laminar flow hood 
No Description 
1 Requirements to be met: 
1.1 Laminar Flow Hoods for product protection only 
1.2 Open type fixed on a base stand 
1.3 Used for the preparation if IV piggy-bags, IV large volume , parentral nutrition 
solutions and all non-chemo intravenous medications 
1.4 Should have pre-filter & HEPA filter & meet all Class 100 conditions 
1.5 Indicator lights for filter conditions, switches for lighting blower ect. Supplied on 
the front panel 
1.6 Supplied with UV lighting 
1.7 Smooth low-maintenance exterior 
1.8 Tempered safety glass on the both sides 
1.9 Fitted with energy efficient motor & blower 
1.10 Work surface should be made of stainless steel AISI 304 
1.11 Bar supports for IV preparations 
1.12 Min. Dimensions 120 x 60 cm for small  or 180 x 80 for medium (approximate) 
1.13 Work area depth min. 45 cm or better 
2 Accessories: 
2.1 Supplied with all accessories 
3 Consumables:  
3.1 Supplied with all consumables 
Pass through refrigerator 
No Description 
1 Requirements to be met: 
1.1 Large refrigerator with both side opening (front & back) – 2 sided. 
1.2 Dimensions W180 x H 220 x D100 all in Cm minimum or better 
1.3 Able to keep the temp. between +2 - +8 with digital display & On/Off button 
1.4 Should have both audio and visual alarm for temperature variation.  
1.5 Made of AISI 304 stainless steel 
1.6 Self- closing glass door with magnetic door seal (replaceable) 
1.7 CFC & HCFC free  
1.8 Slotted rack provided for wire shelf fixing min. 6 racks  
1.9 Capacity not less than 2000 liters. 
1.10 Insulation with high density expanded polyurethane foam min.70mm thickness 
1.11 Contains an Auto-defrost system  
2 Accessories: 
2.1 Supplied with all accessories 
3 Consumables:  
3.1 Supplied with all consumables 
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Medications refrigerator 
No Description 
1 Requirements to be met: 
1.1 Pharmacy/Medical type refrigerator- capacity of 270 liter minimum 
1.2 Dimensions H 150-170CM X W 70-80CM X L 60-70CM 
1.3 Temperature range limit +2 - + 80 C 
1.4 A digital temperature display with audio and visual warning for variations with 
key controlled On/Off 
1.5 With safety control device against freezing 
1.6 Should have molded shelf guides, minimum 6 shelves 
2 Accessories: 
2.1 Supplied with all accessories 
3 Consumables:  
3.1 Supplied with all consumables 
Trolleys large for unit dose 
No Description 
1 Requirements to be met: 
1.1 Stainless steel carts for transportation of the cassettes to different locations 
1.2 Able to accommodate at least 4 cassettes back to back in one shelf 
1.3 Two sides closed and, front& back side open ,supplied with vinyl cover with Zip 
for transportation 
1.4 Min. 3 shelves with wire type 
1.5 Mobile on rubber castors 8 inch at least non-marking, anti-static lockable type 
1.6 Overall size approx. D 35 x H 150 x W 110 all in cm  
2 Accessories: 
2.1 Supplied with all accessories 
3 Consumables:  
3.1 Supplied with all consumables 
Controlled medications cabinet 
No Description 
1 Requirements to be met: 
1.1 Wall Mounted 
1.2 Mild steel epoxy coated 
1.3 Double door cabinet, with adjustable shelves, 5 minimum. 
1.4 Approx. dimension  98x 28 x90 or better (all in cms)  
1.5 Lockable (cam type) with 3 keys, heavy duty lock 
1.6 External visual WARNING light 
2 Accessories: 
2.1 Supplied with all accessories 
3 Consumables:  
3.1 Supplied with all consumables 
Book case for filling 
 
No Description 
1 Requirements to be met: 
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1.1 Able to keep standard box files 
1.2 Full height moulded high quality steel structure 
1.3 Floor based 
1.4 High grade enamel or powder epoxy finish 
1.5 4 adjustable shelves 
1.6 Apprx. Dimensions W100cm - H180cm - D45cm  
2 Accessories: 
2.1 Supplied with all accessories 
3 Consumables:  
3.1 Supplied with all consumables 
Modular storage bins 
No Description 
1 Requirements to be met: 
1.1 Able to store Medications 
1.2 Light weight, rugged, easy access and visibility 
1.3 Stackable, nestable and dividable 
1.4 Made of polypropylene material 
1.5 Able insert labels 
1.6 Should be in the following sizes approx 
25 x 20 x 12 cm for large 
25 x 10 x 8  cm for medium 
2 Accessories: 
2.1 Supplied with all accessories 
3 Consumables:  
3.1 Supplied with all consumables 
Fax machine 
No Description 
1 Requirements to be met: 
1.1 Desktop Facsimile Transceiver, Laser  type 
1.2 Multi copying facility 90 copies at least 
1.3 Reduction/ Enlargement 50 - 200% 
1.4 Storing capacity 500 pages at least 8 MB 
1.5 Broadcasting 150 locations 
1.6 Quick scan 
1.7 Error correction mode  
1.8 Automatic document feeder ( 20 pages at least) 
1.9 Min. 200 sheets plain paper cassette tray 
1.10 Auto reduction for incoming documents 
1.11 Built in telephone hand set preferable 
 
2 Accessories: 
2.1 Supplied with all accessories 
3 Consumables:  
3.1 Supplied with all consumables 
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Chair stool height adjustable 
No Description 
1 Requirements to be met: 
1.1 Seat approx. dimensions W48cm - D45cm - H52cm (back) 
1.2 Gas type height adjustment approx. 40 - 75 cm 
1.3 Adjustable foot ring that moves with height adjust preferable 
1.4 Heavy duty synthetic or metallic base 
1.5 Foam padded with Real Leather fabric for back and seat 
1.6 Swivel style soft dual wheel  Anti-static, Non-marking castors  
1.7 Chair should be of very good quality 
1.8 Preferable colors Black, grey or Brown 
2 Accessories: 
2.1 Supplied with all accessories 
3 Consumables:  
3.1 Supplied with all consumables 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix G 
PN order form 
        *Adapted from (Jacobs, et al 2002; Mirtallo et al, 2004; Kumpf et al, 2005 and    
        Forchelli and Miller, 2005). 
Diagnosis:___________________     
TPN Indication:_______________          
Central line  Peripheral line                   
 
Patient’s Name: __________________ 
Patient’s ID:______________ 
Age:_____ yrs    Sex: M ___F___ 
Date_______ Time______                                Pt’s Wt______ Pt’s Ht_____ 
 
Day of TPN______      Infusion Rate_____ mL/hr  Total volume ____mL/day 
Volume per 24hrs 
Additive Usual Adult daily Requirement Dose per Day  Pharmacy Calculations 
 
Amino Acid 15%   10% 
 
Dextrose ___%       
70% 
 
Sodium Chloride 
Sodium Acetate 
Sodium Phosphate 
Potassium Chloride 
Potassium Acetate 
Potassium Phosphate 
Magnesium Sulphate 
Calcium Gluconate 
Multivitamin 
Trace Element 
Ranitidine 
Zinc 
Other:  
 
0.7-1.7 g/kg/day 
2.5 -6 g/kg/day 
 
1-2 mEq Na/kg/day 
PRN for acidocis 
20-40 mMol 
1-2 mEq K/kg/day 
PRN for acidocis 
20-40 mMol 
8-24 mEq 
5-15 mEq 
Verify 
Verify 
50-150mg/day 
PRN for diarrhea 
 
 
 
________g 
________g 
 
_____ mEq 
_____ mEq 
 _____ mMol 
_____  mEq 
_____  mEq 
_____ mMol 
_____ mEq 
_____ mEq 
Brand________ 
Brand________ 
_____ mg 
_____ mg 
 
 
 
 
Osmolarity 
 
____mL Final 
conc___% 
____mL Final 
Conc___% 
 
_____ mL 
_____ mL 
_____ mL 
_____ mL 
_____ mL 
_____ mL 
_____ mL 
_____ mL 
_____ mL 
_____ mL  
_____ mL 
_____ mL 
 
SWI ______mL 
Total vol ______mL 
=______mOsm/L 
Maximum allowed Osmolarity for peripheral TPN for Adults = 900 mOsm/L& Dex coc. 12.5%.   Appr. 
TPN Osmolarity = ( Final AA% x 100)+(Final Dextrose% x 50) + (Electrolytes Osm /L) 
IV Lipids 20% 0.5–1.5 g/kg/day ________g Infusion Rate_____ mL/hr Over _____ hrs 
Pharmacist Name / Signature: __________________Date/Time _______________ 
Doctor Name / Signature:______________________ Date/Time_______________ 
Calculated by ______ 
Checked by ________ 
Prepared 
by_______ 
Checked 
by______ 
Administration 
Nurse_____________ 
Date/Time__________ 
  
Appendix H 
 
Standard PN label format/Adult 
 
 
 
Hospital/pharmacy name 
 
 
Patient name: ________ MR# ________ Dosing weight ________   
Ward/room# _________ 
Administration date/time ___________ Expiration date/time ___________ 
Base formula                                       Amount/day                               Amount/L 
________________________________________________________________________________________ 
 Dextrose                                                          g                                                                g/L 
 Amino Acids                                                   g                                                                g/L 
 IV Lipids                                                         g                                                                g/L 
Electrolytes  
 Sodium Chloride                                             mEq                                                          mEq/L 
 Sodium Acetate                                               mEq                                                          mEq/L 
 Sodium Phosphate                                           mmol of phosphate                                  mmol/L 
                                                                          mEq of Na                                               mEq/L       
 Potassium Chloride                                         mEq                                                          mEq/L       
 Potassium Acetate                                           mEq                                                         mEq/L       
 Potassium Phosphate                                       mmol of phophate                                   mmol/L 
                                                                          mEq of K                                                 mEq/L      
Magnesium Sulphate                                        mEq                                                         mEq/L                          
Calcium Gluconate                                           mEq                                                       mEq/L      
Vitamins, trace elements and medications 
Multivitamin                                                    ml  
Trace elements                                                 ml 
Rantidine                                                          mg 
Zinc                                                                  mg      
Other: ____________                                      ___     
______________________________________________________________________________________ 
Rate_____ mL/hour            Volume ____ml                  infuse over _________ hours      
Admixture contains __________ml plus __________ ml overfill 
 
 
Discard unused volume after 24 hours 
Central line use only 
 
 
 
         *Adapted from (Mirtallo et al, 2004 and Kumpf et al, 2005). 
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